<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Nat Commun</journal-id><journal-id journal-id-type="iso-abbrev">Nat Commun</journal-id><journal-title-group><journal-title>Nature Communications</journal-title></journal-title-group><issn pub-type="epub">2041-1723</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39138174</article-id><article-id pub-id-type="pmc">PMC11322707</article-id>
<article-id pub-id-type="publisher-id">50524</article-id><article-id pub-id-type="doi">10.1038/s41467-024-50524-5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>PTPN2 copper-sensing relays copper level fluctuations into EGFR/CREB activation and associated <italic>CTR1</italic> transcriptional repression</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2115-9806</contrib-id><name><surname>Ross</surname><given-names>Matthew O.</given-names></name><address><email>matthewross@uchicago.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5105-7136</contrib-id><name><surname>Xie</surname><given-names>Yuan</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0532-5915</contrib-id><name><surname>Owyang</surname><given-names>Ryan C.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0236-5671</contrib-id><name><surname>Ye</surname><given-names>Chang</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1887-4112</contrib-id><name><surname>Zbihley</surname><given-names>Olivia N. P.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4597-1604</contrib-id><name><surname>Lyu</surname><given-names>Ruitu</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9968-9909</contrib-id><name><surname>Wu</surname><given-names>Tong</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Pingluan</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Karginova</surname><given-names>Olga</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9936-1599</contrib-id><name><surname>Olopade</surname><given-names>Olufunmilayo I.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5832-6060</contrib-id><name><surname>Zhao</surname><given-names>Minglei</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4319-7424</contrib-id><name><surname>He</surname><given-names>Chuan</given-names></name><address><email>chuanhe@uchicago.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/024mw5h28</institution-id><institution-id institution-id-type="GRID">grid.170205.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7822</institution-id><institution>Department of Chemistry, </institution><institution>University of Chicago, </institution></institution-wrap>Chicago, IL USA </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/024mw5h28</institution-id><institution-id institution-id-type="GRID">grid.170205.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7822</institution-id><institution>Department of Biochemistry and Molecular Biology, </institution><institution>University of Chicago, </institution></institution-wrap>Chicago, IL USA </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/024mw5h28</institution-id><institution-id institution-id-type="GRID">grid.170205.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7822</institution-id><institution>Department of Medicine, Center for Clinical Cancer Genetics and Global Health, </institution><institution>University of Chicago, </institution></institution-wrap>Chicago, IL USA </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/024mw5h28</institution-id><institution-id institution-id-type="GRID">grid.170205.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7822</institution-id><institution>Howard Hughes Medical Institute, </institution><institution>University of Chicago, </institution></institution-wrap>Chicago, IL USA </aff></contrib-group><pub-date pub-type="epub"><day>13</day><month>8</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>13</day><month>8</month><year>2024</year></pub-date><pub-date pub-type="collection"><year>2024</year></pub-date><volume>15</volume><elocation-id>6947</elocation-id><history><date date-type="received"><day>30</day><month>8</month><year>2023</year></date><date date-type="accepted"><day>10</day><month>7</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2024, corrected publication 2025</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par2">Fluxes in human copper levels recently garnered attention for roles in cellular signaling, including affecting levels of the signaling molecule cyclic adenosine monophosphate. We herein apply an unbiased temporal evaluation of the signaling and whole&#x000a0;genome transcriptional activities modulated by copper level fluctuations to identify potential copper sensor proteins responsible for driving these activities. We find that fluctuations in physiologically&#x000a0;relevant copper levels modulate EGFR signal transduction and activation of the transcription factor CREB. Both intracellular and extracellular assays support Cu<sup>1+</sup>&#x000a0;inhibition of the EGFR&#x000a0;phosphatase PTPN2 (and potentially PTPN1)&#x02013;via ligation to the PTPN2 active site cysteine side chain&#x02013;as the underlying mechanism. We additionally show <italic>i</italic>) copper supplementation drives weak transcriptional repression of the copper importer <italic>CTR1</italic> and <italic>ii</italic>) CREB activity is inversely correlated with <italic>CTR1</italic> expression. In summary, our study reveals PTPN2 as a physiological copper sensor and defines a regulatory mechanism linking feedback control of copper&#x000a0;stimulated EGFR/CREB&#x000a0;signaling and <italic>CTR1</italic> expression.</p></abstract><abstract id="Abs2" abstract-type="web-summary"><p id="Par3">Copper level fluctuations are shown to modulate EGFR signal transduction via inhibition of the phosphatase PTPN2, culminating in CREB transcription factor activity, which is associated with transcriptional repression of the copper importer CTR1.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Metalloproteins</kwd><kwd>Molecular biology</kwd><kwd>Cell signalling</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000066</institution-id><institution>U.S. Department of Health &#x00026; Human Services | NIH | National Institute of Environmental Health Sciences (NIEHS)</institution></institution-wrap></funding-source><award-id>R01ES030546</award-id><award-id>K99ES034084</award-id><principal-award-recipient><name><surname>Ross</surname><given-names>Matthew O.</given-names></name><name><surname>He</surname><given-names>Chuan</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000051</institution-id><institution>U.S. Department of Health &#x00026; Human Services | NIH | National Human Genome Research Institute (NHGRI)</institution></institution-wrap></funding-source><award-id>HG006827</award-id><principal-award-recipient><name><surname>He</surname><given-names>Chuan</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>U.S. Department of Health &#x00026; Human Services | NIH | National Institute of Environmental Health Sciences (NIEHS)</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>University of Chicago Yen Postdoctoral Fellowship</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/100001006</institution-id><institution>Breast Cancer Research Foundation (BCRF)</institution></institution-wrap></funding-source><award-id>FP049439</award-id><principal-award-recipient><name><surname>Olopade</surname><given-names>Olufunmilayo I.</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Nature Limited 2024</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par4">Copper is an essential nutrient in the human diet with prototypical roles as metalloenzyme cofactors; however, excess copper induces cellular (redox) stress via formation of reactive oxygen/nitrogen species. Relatedly, the biochemical mechanisms regulating intracellular copper levels have been extensively characterized. There are two mammalian copper importers; the cuprous importer CTR1 (encoded by the <italic>SLC31A1</italic> gene)&#x02014;responsible for the vast majority of copper internalization&#x02014;and the cupric importer DMT1 (encoded by the <italic>SLC11A2</italic> gene). For expediency, we hereafter refer to the <italic>SLC31A1</italic> and <italic>SLC11A2</italic> genes and transcripts as <italic>CTR1</italic> and <italic>DMT1</italic>, respectively. Following reduction to Cu<sup>1+</sup> and import, copper is shuttled inside the cell by chaperone proteins (e.g., ATOX1) to subcellular locations for metallocofactor assembly or export.</p><p id="Par5">Copper influx and efflux stimulate a wide range of human cellular responses, including cuproplasia (copper&#x000a0;dependent cell growth and proliferation)<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>, cuproptosis<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref></sup>, neuronal activities<sup><xref ref-type="bibr" rid="CR3">3</xref>&#x02013;<xref ref-type="bibr" rid="CR5">5</xref></sup>, cell differentiation<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>, and the epithelial&#x000a0;to&#x000a0;mesenchymal transition in cancer<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>, as well as signaling pathways such as cyclic adenosine monophosphate (cAMP) signaling<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>, MAPK/ERK, JAK-STAT, PI3K/Akt, NF-&#x003ba;B, and the NOD-like receptor protein 3 (NLRP3) inflammasome<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. Furthermore, copper dyshomeostasis causes human diseases such as Menkes syndrome and Wilson disease, and elevated copper levels induce numerous pro-cancer activities (e.g., angiogenesis, metastasis, and cell proliferation)<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. Relatedly, serum and tissue copper levels correlate with carcinogenesis and prognosis across diverse cancers<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. Targeting copper homeostasis pathways has been proposed as promising therapeutic approaches against diverse diseases, including cancer<sup><xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR13">13</xref></sup>.</p><p id="Par6">Across the tree of life, copper stimulates cellular signaling/processes through either indirect mechanisms (change in cellular redox status, generic metal dyshomeostasis response, etc.) or direct binding to proteins. Common bacterial and yeast examples of the latter include copper&#x000a0;sensing transcription factors (TFs), which alter copper&#x000a0;homeostasis protein expression levels to regulate intracellular copper concentrations. In humans, it was recently discovered that copper binding to the enzyme PDE3B inhibits its cAMP&#x000a0;degrading function, leading to elevated levels of the signaling molecule cAMP<sup><xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR14">14</xref></sup>. However, considerably less is known about the transcriptional programs altered by copper levels in humans; whether mammalian intracellular copper levels are even regulated by differential transcriptional/translational expression of copper&#x000a0;homeostasis proteins has been an ongoing debate<sup><xref ref-type="bibr" rid="CR15">15</xref>&#x02013;<xref ref-type="bibr" rid="CR17">17</xref></sup>.</p><p id="Par7">In this report, we apply an unbiased temporal evaluation of the whole&#x000a0;genome transcriptional activities stimulated by fluctuations in copper levels under normal cellular growth conditions. We first employ the recently developed kethoxal&#x000a0;assisted single&#x000a0;stranded DNA (ssDNA)&#x000a0;sequencing (KAS-seq) technique<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>, which reports genomic ssDNA regions (corresponding to active transcription), to evaluate the transcriptional programs immediately activated following copper supplementation. By pairing these results with phosphorylation arrays to define copper&#x000a0;stimulated signal transduction pathways, as well as transcriptomic, molecular biological, and biochemical investigations, we produce strong evidence that low level copper supplementation causes Cu<sup>1+</sup> binding to&#x02013;and inactivation of&#x02013;the protein tyrosine phosphatase (PTP) PTPN2 at the active site cysteine to drive activation of EGFR signal transduction, leading to MAPK/ERK/CREB (cAMP response element binding protein) activation. Moreover, we show elevated copper levels, whether supplemented into the extracellular media or via direct intracellular release using a copper ionophore, drive weak <italic>CTR1</italic> repression, and that CREB activity is inversely correlated with <italic>CTR1</italic> expression. We propose this pathway likely serves as a feedback response to balance copper&#x000a0;uptake and attenuate copper&#x000a0;stimulated cAMP signaling, working in concert with other established mechanisms like copper&#x000a0;stimulated CTR1 protein degradation<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. Thus, copper&#x000a0;/CREB&#x000a0;stimulated <italic>CTR1</italic> transcriptional repression may drive the previously reported ~70% decrease in <italic>CTR1</italic> transcript levels following sustained activation of CREB and intracellular copper accumulation during neuronal differentiation<sup><xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR20">20</xref>&#x02013;<xref ref-type="bibr" rid="CR23">23</xref></sup>.</p></sec><sec id="Sec2" sec-type="results"><title>Results</title><sec id="Sec3"><title>Rapid copper&#x000a0;stimulated transcriptional/signaling responses</title><p id="Par8">KAS-seq provides a genomic method that enables temporal profiling of the whole&#x000a0;genome transcriptional activity to identify early responsive genes upon cellular stimulation or signaling. To study copper-induced signaling we applied KAS-seq to evaluate the genomic responses of A549 cells (non-small cell lung adenocarcinoma) to 10&#x02009;&#x000b5;M CuCl<sub>2</sub> (low Cu) or 20&#x02013;30&#x02009;&#x000b5;M CuCl<sub>2</sub> (high Cu) supplemented growth media for 15&#x02009;min, 2&#x02009;h, and 4&#x02009;h, relative to unsupplemented cells (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1a</xref>). For reference, healthy serum copper levels are ~10&#x02013;30&#x02009;&#x000b5;M (of which ~25% is readily exchangeable<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>), while up to ~3-fold increases have been observed in cancer patients<sup><xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR25">25</xref></sup>. Through KAS-seq we captured the sequence of copper&#x000a0;stimulated transcriptional responses (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1b</xref>, Supplementary Figs.&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>&#x02013;<xref rid="MOESM1" ref-type="media">2</xref>, Supplementary Data&#x000a0;<xref rid="MOESM4" ref-type="media">1</xref>), including the immediately&#x000a0;activated genes first induced by copper stimulation. Examining the gene body differential ssDNA levels revealed three genes significantly activated by both low and high copper incubation conditions: <italic>EGR1</italic> and <italic>NR4A1</italic> (15&#x02009;min post-copper) as well as <italic>CXCL2</italic> (2&#x02009;h post-copper), all of which are established CREB1 target genes<sup><xref ref-type="bibr" rid="CR26">26</xref></sup> and are induced by the MAPK/ERK signal transduction pathway<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>.<fig id="Fig1"><label>Fig. 1</label><caption><title>EGFR/MAPK/ERK signaling and associated gene regulation.</title><p><bold>a</bold> Schematic of the various techniques applied in this study to evaluate copper&#x000a0;stimulated transcriptional/genomic dynamics, with the canonical EGFR/MAPK/ERK signaling pathway. Figure&#x000a0;1/panel a created with BioRender.com released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license. <bold>b</bold> A549 KAS-seq gene body volcano plots (Cu-supplemented vs. unsupplemented) 15&#x02009;min post-cell treatment. Significantly upregulated genes in red; horizontal gray lines denote <italic>p</italic>&#x02009;=&#x02009;0.05; <italic>n</italic>&#x02009;=&#x02009;2 biological replicates for each condition. Low Cu and High Cu conditions correspond to 10 and 20&#x02009;&#x000b5;M CuCl<sub>2</sub> supplementation, respectively. <italic>p</italic>-value denotes two-sided Wald test as calculated by DESeq2, without correction for multiple observations. <bold>c</bold> Changes in HEK 293&#x02009;T phosphorylation and/or total protein levels from proteome profiler phospho-kinase antibody arrays following 10&#x02009;min, 20&#x02009;&#x000b5;M CuCl<sub>2</sub> treatment (vs. untreated). <italic>n</italic>&#x02009;=&#x02009;3 biological replicates for each condition. <italic>p</italic>-value denotes two-sided t-test without correction for multiple observations. <bold>d</bold> RNA-qPCR fold-changes of select transcripts following copper supplementation for indicated times into A549 cells. Box plot values defined as follows: box boundaries (median of first quartile to median of third quartile) and central horizontal line (median), mean expression value shown on the plot as an &#x0201c;x&#x0201d;, whisker boundaries define 1.5 times the interquartile range. Data points correspond to biological replicates, <italic>p</italic>-values calculated as paired two-tailed <italic>t</italic>-test. Sample sizes were as follows for each transcript at 60&#x02009;min, 120&#x02009;min, and 240&#x02009;min post-Cu; <italic>EGR1</italic> (<italic>n</italic>&#x02009;=&#x02009;2, 6, 10), <italic>NAB1</italic> (<italic>n</italic>&#x02009;=&#x02009;2, 6, 6), <italic>NAB2</italic> (<italic>n</italic>&#x02009;=&#x02009;2, 6, 6), <italic>CTR1</italic> (<italic>n</italic>&#x02009;=&#x02009;2, 2, 10&#x02013;22). Source data are provided as a Source Data file, as are exact <italic>p</italic>-values. * denotes <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, ** denotes <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01, and *** denotes <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001.</p></caption><graphic xlink:href="41467_2024_50524_Fig1_HTML" id="d33e581"/></fig></p><p id="Par9">The implied MAPK/ERK pathway activation by copper led us to evaluate changes in phosphorylation and total protein levels among common signal transduction proteins via proteome profiler phospho-kinase antibody arrays. Because A549 cells express mutant hyperactive KRAS and overexpress EGFR, which could obfuscate detection of copper&#x000a0;stimulated MAPK/ERK activation, we selected a non-cancerous cell line for further validation and investigation. HEK 293&#x02009;T cells were briefly (3&#x02009;h) serum&#x000a0;starved to attenuate serum-responsive signaling, then were supplemented with 20&#x02009;&#x000b5;M CuCl<sub>2</sub>. 10&#x02009;min post-copper supplementation, cells were lysed and evaluated via the array relative to unsupplemented cell lysates (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">3</xref>). AKT phosphorylation was strongly, significantly diminished in response to copper treatment&#x02014;interestingly, diminished AKT signaling was also previously detected when glial cells were treated with a cell&#x000a0;permeable small molecule copper chelate<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. There were two significantly activated protein phosphorylation sites: EGFR Y-1086 and CREB1 S-133 (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1c</xref>).</p><p id="Par10">Phosphorylation of EGFR Y-1086 (as well as Y-1068) activates MAPK/ERK signaling<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>, which subsequently drives phosphorylation of the nuclear TF CREB1 S-133 site<sup><xref ref-type="bibr" rid="CR30">30</xref></sup> (among other TFs). The KAS-seq and phosphorylation array results collectively indicate that low level copper supplementation drives EGFR activation to initiate copper&#x000a0;stimulated MAPK/ERK signaling, followed by downstream CREB1 activation and transcriptional responses.</p></sec><sec id="Sec4"><title>Copper drives EGFR, CREB activation and weak <italic>CTR1</italic> repression</title><p id="Par11">To corroborate the transcriptional activities reported by KAS-seq and provide more quantitative assessment of this potential copper&#x000a0;induced MAPK/ERK signal transduction, we performed RNA-qPCR to analyze copper homeostasis (<italic>ATOX1</italic> and <italic>CTR1</italic>) and MAPK/ERK&#x000a0;induced (<italic>EGR1</italic>, <italic>NAB1</italic>, and <italic>NAB2</italic>) transcript expression levels from cells supplemented with 0&#x02013;200&#x02009;&#x000b5;M CuCl<sub>2</sub>. All RNA-qPCR transcript expression levels are reported as fold-change relative to cells in media without CuCl<sub>2</sub> supplementation. As expected, <italic>ATOX1</italic> expression levels were unresponsive to copper supplementation (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">4</xref>). We measured a dose&#x000a0;dependent increase in <italic>EGR1</italic> expression 1&#x02009;h post-copper supplementation, followed by increased <italic>NAB1</italic> and <italic>NAB2</italic> expression 1&#x02013;3&#x02009;h later (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1d</xref>). <italic>NAB1</italic>/<italic>2</italic> expression is known to be strongly induced 1&#x02009;h after MAPK/ERK&#x000a0;induced <italic>EGR1</italic> expression<sup><xref ref-type="bibr" rid="CR31">31</xref>,<xref ref-type="bibr" rid="CR32">32</xref></sup>. <italic>CTR1</italic> was weakly repressed 4&#x02009;h after &#x02265;100&#x02009;&#x000b5;M copper supplementation, consistent with prior RNase protection experiments<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. We subsequently performed RNA-seq and confirmed that these copper&#x000a0;stimulated changes in <italic>NAB1</italic>, <italic>NAB2</italic>, and <italic>CTR1</italic> expression levels were again detected 4&#x02009;h post-copper supplementation (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">5</xref>). Pre-treatment of A549 cells with EGFR-inhibitors (2&#x02009;&#x000b5;M gefitinib or 80&#x02009;&#x000b5;g/mL cetuximab) followed by copper supplementation and RNA-qPCR validated copper&#x000a0;stimulation of EGFR signaling as the driver of increased <italic>EGR1</italic> expression and <italic>CTR1</italic> repression (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">6</xref>). Knockdown or overexpression of <italic>DMT1</italic> had no significant effect on copper&#x000a0;stimulated <italic>EGR1</italic> expression activation (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">7</xref>).</p><p id="Par12">Our observation of copper&#x000a0;stimulated EGFR activation suggested that MAPK/ERK&#x000a0;downstream TFs may be responsible for <italic>CTR1</italic> transcriptional repression. As our results defined copper supplementation drives CREB phosphorylation&#x02014;and given the aforementioned role of copper in cAMP signaling&#x02014;we evaluated CREB as the candidate copper&#x000a0;stimulated <italic>CTR1</italic>&#x000a0;repressor TF. We analyzed previous chromatin immunoprecipitation-sequencing (ChIP-seq) experiments, and found significant CREB1 binding to the <italic>CTR1</italic> promoter in the majority of human cell lines in the ChIP-Atlas as well as in the CREB Target Gene Database<sup><xref ref-type="bibr" rid="CR33">33</xref>&#x02013;<xref ref-type="bibr" rid="CR35">35</xref></sup> (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2a</xref>, Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">8</xref>, Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>). The <italic>CTR1</italic> promoter <italic>CRE</italic> (cAMP response element) does not contain a proximal TATA box (Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>), the presence of which is generally associated with CREB&#x000a0;induced gene expression<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>, consistent with a role of CREB&#x000a0;induced <italic>CTR1</italic> repression.<fig id="Fig2"><label>Fig. 2</label><caption><title>Transcriptomic correlations of MAPK/ERK/CREB1 activation and <italic>CTR1</italic> repression.</title><p><bold>a</bold> Mean enrichment of CREB1 ChIP-seq experiments generated from ChIP-Atlas <italic>Homo sapiens</italic> cell lines (<italic>Top</italic>) and <italic>Mus musculus</italic> tissues and blood (<italic>Bottom</italic>). Individual ChIP-seq experiments presented in SI Appendix Fig. S7. <bold>b</bold> A549 <italic>CTR1</italic> transcript level box plots following modulation of CREB activity levels. (<italic>Left</italic>) 24&#x02009;h post-CREB1-knockdown, relative to cells transfected with negative control (non-targeting) siRNA. <italic>n</italic>&#x02009;=&#x02009;3 biological replicates for each condition. (<italic>Middle</italic>) 24&#x02009;h after 2.56&#x02009;&#x000b5;M CREB inhibitor 666-15 treatment relative to cells treated with DMSO. <italic>n</italic>&#x02009;=&#x02009;6 biological replicates for each condition. (<italic>Right</italic>) 24&#x02009;h after transfection of a pCMV-CREB1 overexpression vector, relative to transfection with a dsRed-EGFP plasmid. <italic>n</italic>&#x02009;=&#x02009;6 biological replicates. Same box plot definitions as in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>. Source data are provided as a Source Data file, as are exact <italic>p</italic>-values. * denotes <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, ** denotes <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01, and *** denotes <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 for two-sided <italic>t</italic>-test comparison between conditions. <bold>c</bold> Correlations of MAPK/ERK/CREB1&#x000a0;stimulated transcript expression levels (nm. cts. is normalized read counts) with <italic>CTR1</italic> levels from healthy human tissue (GTEx) transcriptomic data. Correlation line shadow corresponds to 95% confidence interval. Not significant correlations (<italic>p</italic>&#x02009;&#x0003e;&#x02009;0.05) covered in gray boxes. Fit statistics provided in Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">3</xref>. <italic>n</italic>&#x02009;=&#x02009;578, 861, 2642, 226, 89 GTEx RNA-seq samples for lung, heart, brain, liver, and kidney tissues, respectively. <bold>d</bold> Boxplots generated from TCGA gene expression data of select MAPK/ERK/CREB1&#x000a0;stimulated transcripts, comparing MAPK/ERK activating KRAS<sup>G12X</sup> mutant relative to non-variant lung adenocarcinoma transcript levels. Box plot values defined as follows: box boundaries (median of first quartile to median of third quartile) and central horizontal line (median of all expression values), numbers below/above individual box plots denote mean expression value of that dataset (shown on the plot as an &#x0201c;x&#x0201d;), whisker boundaries define 1.5 times the interquartile range; outlier data points omitted for visual clarity. <italic>n</italic>&#x02009;=&#x02009;362 and 131 samples for KRAS non-variant and KRAS<sup>G12X</sup> samples, respectively. * denotes <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, ** denotes <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01, and *** denotes <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 for two-sided <italic>t</italic>-test comparison between conditions.</p></caption><graphic xlink:href="41467_2024_50524_Fig2_HTML" id="d33e863"/></fig></p><p id="Par13">We then sought direct experimental evidence of CREB&#x000a0;induced <italic>CTR1</italic> repression. We first evaluated <italic>CTR1</italic> levels in A549 cells via RNA-qPCR following <italic>CREB1</italic>-siRNA transfection (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2b</xref>, knockdown validation provided in Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">9</xref>); <italic>CREB1</italic> knockdown significantly increased <italic>CTR1</italic> expression. Notably, the same results were also observed in a <italic>CREB1</italic>&#x000a0;knockdown RNA-seq study in K562 (leukemia) cells (Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">2</xref>)<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>. We next assessed chemical inhibition of CREB1 via supplementation of the small molecule CREB inhibitor 666-15, and similarly found <italic>CTR1</italic> levels were significantly increased (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2b</xref>). By contrast, we found cells transfected with a pCMV vector driving constitutive <italic>CREB</italic> expression significantly (albeit weakly) repressed <italic>CTR1</italic> levels (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2b</xref>). Collectively, these results revealed CREB as the downstream copper&#x000a0;stimulated repressor TF of <italic>CTR1</italic>.</p></sec><sec id="Sec5"><title>NGS&#x000a0;repositories support a link between CREB and <italic>CTR1</italic> levels</title><p id="Par14">To demonstrate physiological relevance of this pathway, we next sought in vivo evidence of <italic>CTR1</italic> repression via CREB. We plotted mean ChIP-signal enrichments from mouse tissue and blood CREB1 ChIP-seq experiments in the ChIP-Atlas (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2a</xref>, Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">8</xref>). These ChIP-seq results confirmed binding of CREB1 at the <italic>Ctr1</italic> promoter inside living mammals. Relatedly, a prior study found mice injected with FGF23 (a MAPK/ERK activator kidney hormone) exhibited pronounced renal repression of <italic>Ctr1</italic><sup><xref ref-type="bibr" rid="CR38">38</xref></sup>.</p><p id="Par15">We next evaluated correlations between <italic>CTR1</italic> levels with expression levels of MAPK/ERK responsive genes (<italic>EGR1</italic>, <italic>NAB1</italic>, and <italic>NAB2</italic>) and the CREB1 target gene <italic>NR4A1</italic> across the five vital organs in healthy human tissues using Genotype-Tissue Expression (GTEx) RNA-seq datasets. We assessed whether activation of the MAPK/ERK/CREB signaling, as inferred by increased <italic>EGR1</italic>, <italic>NAB1</italic>, <italic>NAB2</italic>, and <italic>NR4A1</italic> expression levels, is associated with repression of <italic>CTR1</italic>. In all tissues, transcript correlations with <italic>CTR1</italic> were negative or statistically insignificant (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2c</xref>, Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">3</xref>). As <italic>EGR1</italic>, <italic>NAB2</italic>, and <italic>NR4A1</italic> expression tend to be transient and stimulus&#x000a0;induced<sup><xref ref-type="bibr" rid="CR39">39</xref>,<xref ref-type="bibr" rid="CR40">40</xref></sup>, the observed inter-tissue&#x000a0;conserved negative correlations support stimulus&#x000a0;responsive <italic>CTR1</italic> repression by CREB1 in vivo. Note that <italic>CREB1</italic> levels are also negatively correlated with <italic>CTR1</italic> levels across the aforementioned tissues (excluding the non-significant correlation in the heart tissue, Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">10</xref>).</p><p id="Par16">For further in vivo evidence, and given the important roles of EGFR/MAPK/ERK/CREB in lung adenocarcinoma, we evaluated the Cancer Genome Atlas (TCGA) lung adenocarcinoma RNA-seq results, comparing MAPK/ERK&#x000a0;activating KRAS<sup>G12X</sup> mutant (X is A, C, D, S, or V) with non-variant samples. As expected, MAPK/ERK&#x000a0;stimulated and CREB1&#x000a0;target gene transcripts were significantly increased while <italic>CTR1</italic> levels were significantly (again, albeit weakly) decreased in KRAS<sup>G12X</sup> mutant relative to non-variant samples (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2d</xref>). Collectively, our results provide strong evidence that <italic>CTR1</italic> expression levels are repressed by CREB activation.</p></sec><sec id="Sec6"><title>Whole&#x000a0;transcriptome profiling of copper&#x000a0;stimulated activities</title><p id="Par17">To investigate this copper&#x000a0;induced regulatory pathway, as well as demonstrate reversibility of the copper&#x000a0;stimulated CREB1 TF&#x000a0;activation response, we next evaluated differences in gene expression across the transcriptome induced by copper&#x000a0;depletion (via supplementation of tetrathiomolybdate (TM)) or copper supplementation using RNA-seq. Note: TM was chosen as a copper&#x000a0;chelator (as opposed to Cu<sup>1+</sup>/Cu<sup>2+</sup>&#x000a0;specific, or intra-/extracellular specific) as a way to sequester both extra- and intracellular copper. We found a close correspondence between transcriptomic responses 2&#x02009;h post-copper supplementation and 24&#x02009;h post-TM supplementation (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3a, b</xref>, Supplementary Data&#x000a0;<xref rid="MOESM5" ref-type="media">2</xref>&#x02013;<xref rid="MOESM6" ref-type="media">3</xref>). Pathway and process enrichment analysis of differentially expressed transcripts (FDR-q&#x02009;&#x0003c;&#x02009;0.05) post-treatment corroborated known copper&#x000a0;stimulated pathways, supporting that these responses are regulated at the transcriptional level. Four ontologies of particular relevance were enriched in both the TM and copper&#x000a0;supplemented differentially expressed genes (that is, transcripts significantly up- or downregulated, Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3c,d</xref>, Supplementary Data&#x000a0;<xref rid="MOESM7" ref-type="media">4</xref>&#x02013;<xref rid="MOESM8" ref-type="media">5</xref>): (i) regulation of (MAP) kinase activity, (ii) response to growth factor (including TGF&#x02010;&#x003b2;&#x02014;an EGFR transactivator<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>&#x02014;response ontologies), as well as the related (iii) epithelial cell differentiation and (iv) cell/tube morphogenesis. Moreover, consistent with the known role of copper in stimulating cellular differentiation, evaluation of transcripts significantly repressed in response to TM also revealed enrichment of terms (iii) and (iv) (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">11</xref>). Of further particular note, the copper&#x000a0;treated dataset revealed enrichment of the response to cAMP ontology, consistent with a role of copper in activating CREB.<fig id="Fig3"><label>Fig. 3</label><caption><title>Transcriptomic changes induced by altered copper levels and/or MAPK/ERK/CREB signaling.</title><p>RNA-seq volcano plots depicting differential expression for <bold>a</bold> MDA-MB-468 cells treated with TM for 24&#x02009;h (relative to DMSO&#x000a0;treated) and <bold>b</bold> A549 cells treated with CuCl<sub>2</sub> (30&#x02009;&#x000b5;M or 200&#x02009;&#x000b5;M) for 2&#x02009;h (relative to unsupplemented). For visual clarity, outlier datapoints omitted from volcano plots; full plots shown in Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">12</xref>. As expected, <italic>MT1X</italic> expression levels (which are correlated to intracellular copper levels following copper supplementation<sup><xref ref-type="bibr" rid="CR55">55</xref>,<xref ref-type="bibr" rid="CR56">56</xref></sup>) were decreased following TM treatment and increased following copper treatment. FDR-q is the false discovery rate&#x000a0;adjusted <italic>p</italic>-value (corrected for multiple observations from the two-sided <italic>p</italic>-value calculated via Wald test by DESeq2). Gray lines denote FDR-q&#x02009;=&#x02009;0.05. <italic>n</italic>&#x02009;=&#x02009;2 (MDA-MB-468) or 3 (A549) biological replicates for each condition. Pathway and process enrichment for significantly differentially expressed transcripts following <bold>c</bold> TM or <bold>d</bold> 30&#x02009;&#x000b5;M CuCl<sub>2</sub> treatment. All enriched ontologies provided in Supplementary Data&#x000a0;<xref rid="MOESM7" ref-type="media">4</xref>&#x02013;<xref rid="MOESM8" ref-type="media">5</xref>. <bold>e</bold> Transcription factor target gene set enrichment analysis (GSEA) depicts the activation of MAPK3 (a.k.a. ERK1) target genes in DMSO-treated relative to TM&#x000a0;treated cells; NES is normalized enrichment score. <bold>f</bold> TF (transcription factor) target enrichment generated from significantly differentially expressed transcripts post-2 h, 30&#x02009;&#x000b5;M CuCl<sub>2</sub> treatment. Multiple CREB hits correspond to different CREB target gene lists. Fully labeled TF target enrichment presented in Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">22</xref>. <bold>g</bold> Heatmaps depicting differential expression of CREB1&#x000a0;target genes (97 assessed in total) following TM or CuCl<sub>2</sub>&#x000a0;treatment. Numbers in red and blue denote upregulated and downregulated CREB1&#x000a0;target genes, respectively. Gene list with corresponding expression values presented in Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">23</xref>. The figure is intended to provide a general assessment of the treatment effects on CREB1&#x000a0;target gene expression&#x02014;discrete lines (corresponding to individual transcripts) should not be compared across conditions and do not necessarily correspond to the same transcript.</p></caption><graphic xlink:href="41467_2024_50524_Fig3_HTML" id="d33e1138"/></fig></p><p id="Par18">While MAPK3 (a.k.a. ERK1) target genes were significantly depleted upon TM treatment, CREB target genes were significantly enriched in the copper&#x000a0;supplemented dataset (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3e,f</xref>). Indeed, copper generally stimulated activation of known CREB1&#x000a0;target genes, whereas TM generally repressed them (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3g</xref>). Finally, <italic>CTR1</italic> levels were significantly increased following TM treatment, further confirming that decreasing bioavailable extracellular copper drives <italic>CTR1</italic> expression (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3a</xref> and Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">12</xref>).</p></sec><sec id="Sec7"><title>The mechanism underlying copper&#x000a0;stimulated EGFR activation</title><p id="Par19">To probe the molecular and biochemical mechanism underlying copper&#x000a0;stimulated EGFR activation, we next applied anti-EGFR phosphorylation arrays to briefly serum-starved (~3&#x02009;h) A549 cell lysates generated from cells supplemented with 20&#x02009;&#x000b5;M CuCl<sub>2</sub> for 15&#x02009;min, relative to unsupplemented cell lysates. An unambiguous, reproducible ~50% decrease in pan-EGFR (total EGFR) levels in response to copper was measured (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">13</xref>). Rapid (sub-hour&#x000a0;timescale) degradation of EGFR is an indicator of a specific interaction with EGFR, generally a conformational change&#x000a0;driven by agonist binding; in contrast to the slow degradation induced by stress conditions<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>. Note that <italic>EGR1</italic> expression was activated by copper supplementation in cells pretreated with metalloproteinase inhibitor to a similar magnitude as non-pretreated cells (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">14</xref>), excluding the possibility copper supplementation leads to activation of metalloproteinases which then cleave pro-growth factors and activate EGFR.</p><p id="Par20">Given the rapid EGFR degradation upon copper supplementation, it was important to evaluate the possibility that extracellular Cu<sup>2+</sup> may directly bind EGFR to activate signaling. To probe Cu<sup>2+</sup>&#x000a0;binding by EGFR, we expressed and purified soluble EGFR&#x000a0;extracellular domain (sEGFR; residues 1-642). While we confirmed sEGFR bound Cu<sup>2+</sup> with a physiologically&#x000a0;relevant K<sub>D</sub> (200&#x02013;700&#x02009;nM; Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">15</xref>), and formed a well&#x000a0;structured Cu<sup>2+</sup> binding site as assessed by electron paramagnetic resonance spectroscopy (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">16</xref>); no Cu<sup>2+</sup>&#x000a0;driven dimerization (as required for ligand&#x000a0;dependent EGFR signal transduction<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>) of sEGFR was detected by mass photometry (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">17</xref>). This contrasts with the recent speculation that Cu<sup>2+</sup> may drive dimerization of EGFR to activate signal transduction<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>. Having excluded copper&#x000a0;stimulated EGFR dimerization as a potential activation mechanism of EGFR signal transduction, we explored a different possibility: that fluctuations in extracellular copper levels could lead to Cu<sup>1+</sup> import and inactivation of EGFR phosphatases, thereby effectively inducing EGFR activation.</p><p id="Par21">The highly homologous (99% catalytic site similarity<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>) proteins PTPN1 and PTPN2 (a.k.a. PTP1B and TCPTP, respectively) are EGFR pY-1068 (and probably pY-1086<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>) phosphatases<sup><xref ref-type="bibr" rid="CR47">47</xref>&#x02013;<xref ref-type="bibr" rid="CR49">49</xref></sup>. Previous studies assessing ex vivo<sup><xref ref-type="bibr" rid="CR50">50</xref>,<xref ref-type="bibr" rid="CR51">51</xref></sup> and in vitro (cellular)<sup><xref ref-type="bibr" rid="CR44">44</xref>,<xref ref-type="bibr" rid="CR52">52</xref></sup> environmental exposure to aberrant levels of copper have suggested metallo-inactivation of PTPN1, via an unknown molecular mechanism, and prior biochemical characterization of PTPN1 revealed strong inhibition of its phosphatase activity by a variety of metals (although Cu<sup>1+</sup> was not assessed)<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>. Relatedly, it was previously shown that PTPN1 overexpression was sufficient to partially block EGFR phosphorylation induced by cell membrane&#x000a0;permeable copper&#x000a0;complexes in glial cells<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. These observations prompted us to consider PTPN1 and PTPN2 as alternative candidates for the copper&#x000a0;sensor(s) responsible for relaying changes in intracellular copper levels into EGFR signaling responses. We subsequently screened siRNA knockdown of several PTPs&#x02014;including established EGFR phosphatases PTPN1, PTPN2, PTPRJ and PTPRG<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>&#x02014;and assessed copper&#x000a0;stimulated EGFR activation by measuring <italic>EGR1</italic> expression level changes. <italic>PTPN2</italic> knockdown significantly diminished copper-stimulated <italic>EGR1</italic> activation in A549 cells; the only <italic>PTP</italic> knockdown to do so (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4a</xref>). This result supports a mechanism of copper&#x000a0;driven activation of EGFR signaling via PTPN2 inactivation in A549 cells. We suspect the weakly decreased <italic>EGR1</italic> levels across most <italic>PTP</italic> knockdowns relative to negative control siRNA transfection are likely due to off-target effect(s) of the negative control siRNA, leading to slightly elevated <italic>EGR1</italic> levels. Indeed, the <italic>DMT1</italic> siRNA knockdown experiment also detected similarly decreased <italic>EGR1</italic> expression levels relative to negative control siRNA transfection (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">7</xref>).<fig id="Fig4"><label>Fig. 4</label><caption><title>Inhibition of PTPN2 is associated with copper&#x000a0;stimulated activation of EGFR.</title><p><bold>a</bold> Evaluation of the effects on <italic>EGR1</italic> expression levels of 200&#x02009;&#x003bc;M CuCl<sub>2</sub> (60&#x02009;min treatment) following siRNA knockdown of various PTPs in A549 cells. Depicted are two interpretations of the results. (<italic>top</italic>) All fold-changes are reported relative to the negative control siRNA transfect (Neg.) without CuCl<sub>2</sub> supplementation. (<italic>bottom</italic>) Each result is reported as the fold-change between the denoted siRNA knockdown after 60&#x02009;min 200&#x02009;&#x003bc;M CuCl<sub>2</sub> supplementation and the siRNA knockdown by itself. (<italic>n</italic>&#x02009;=&#x02009;3 replicates per condition). Same box plot definitions as in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>. * denotes <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, ** denotes <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01, and *** denotes <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 for two-sided <italic>t</italic>-test comparison between conditions. <bold>b</bold>
<italic>p</italic>NPP (<italic>p</italic>-nitrophenyl phosphate) assay of &#x00394;PTPN1 PTP activity following addition of various amounts of Cu<sup>1+</sup> (<italic>n</italic>&#x02009;=&#x02009;12 replicates per condition). <bold>c</bold> Proteome profiler antibody array volcano plot depicting statistically&#x000a0;significant increases in phosphorylation levels following HEK 293&#x02009;T supplementation with 20&#x02009;&#x003bc;M ZnCl<sub>2</sub>. (<italic>n</italic>&#x02009;=&#x02009;2 replicates for each conditio<italic>n</italic>). <bold>d</bold> Changes in A549 <italic>EGR1</italic> expression levels 60&#x02009;min after ZnCl<sub>2</sub> supplementation. The fold-changes are overlayed on the fold-changes induced by CuCl<sub>2</sub> supplementation for reference. (<italic>n</italic>&#x02009;=&#x02009;2 replicates per condition). Same box plot definitions as in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>. <bold>e</bold> RNA-qPCR fold-changes of select transcripts 4&#x02009;h post-supplementation of 500&#x02009;nM CuGTSM or 5&#x02009;&#x000b5;M CS1 relative to DMSO&#x000a0;treated A549 cells. (<italic>n</italic>&#x02009;=&#x02009;3 replicates per condition). Data points correspond to biological replicates, <italic>p</italic>-values calculated as paired two-tailed t-test. Same box plot definitions as in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>. Figure&#x000a0;4a, b, d, and e source data are provided as a Source Data file, as are exact <italic>p</italic>-values for Fig.&#x000a0;4a, e. * denotes <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, ** denotes <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01, and *** denotes <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 for two-sided <italic>t</italic>-test comparison between conditions.</p></caption><graphic xlink:href="41467_2024_50524_Fig4_HTML" id="d33e1426"/></fig></p><p id="Par22">For PTPN2 to function as a copper sensor, it should be more sensitive to fluctuations in intracellular copper levels than established copper-stress response biomarkers. Elevated expression of the metallothionein <italic>MT1X</italic> is an established biomarker of intracellular copper stress driven by copper supplementation<sup><xref ref-type="bibr" rid="CR54">54</xref>&#x02013;<xref ref-type="bibr" rid="CR56">56</xref></sup>. We consequently evaluated changes in A549 <italic>MT1X</italic> expression via qPCR for the same CuCl<sub>2</sub> supplementation concentrations and incubation times as assessed previously. Only copper levels &#x02265;100&#x02009;&#x003bc;M drove elevated <italic>MT1X</italic> expression (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">18</xref>), far greater than the copper supplementation levels at which we previously detected significant EGFR activation and <italic>EGR1</italic> expression (20&#x02009;&#x003bc;M and 10&#x02009;&#x003bc;M CuCl<sub>2</sub>, respectively) through PTPN2.</p><p id="Par23">PTPN1 and PTPN2 dephosphorylate signal transduction proteins to attenuate signaling via a highly&#x000a0;acidic active site cysteine. While Cu<sup>2+</sup> and other divalent metals are known to inactivate PTPN1, to the best of our knowledge, no biochemical assessment of Cu<sup>1+</sup>&#x000a0;binding nor inactivation of PTPN1 has been performed<sup><xref ref-type="bibr" rid="CR57">57</xref>&#x02013;<xref ref-type="bibr" rid="CR59">59</xref></sup>. As the PTPN1 and PTPN2 catalytic domains are highly homologous, and considerably more metallo-inactivation experiments have been performed on PTPN1, we recombinantly expressed and purified the PTPN1 catalytic domain (&#x00394;PTPN1; residues 1-301), and subsequently evaluated Cu<sup>1+</sup>&#x000a0;binding. We found that addition of excess Cu<sup>1+</sup> to &#x00394;PTPN1 resulted in the protein binding&#x000a0;of 5.4&#x02009;&#x000b1;&#x02009;0.47 (<italic>n</italic>&#x02009;=&#x02009;3) equivalents&#x000a0;of copper, as measured by ICP-MS, and &#x00394;PTPN1 activity was inhibited following incubation with Cu<sup>1+</sup> (as assessed by the <italic>p</italic>-nitrophenyl phosphate (<italic>p</italic>NPP) assay, Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4b</xref>). The active site cysteine mutant C215S &#x00394;PTPN1 bound 4.6&#x02009;&#x000b1;&#x02009;0.26 (<italic>n</italic>&#x02009;=&#x02009;3) Cu<sup>1+</sup> equivalents, indicating that the active site cysteine residue binds Cu<sup>1+</sup>, and that the mechanism of the Cu<sup>1+</sup>&#x000a0;driven inhibition involves Cu<sup>1+</sup> binding to the active site cysteine. By contrast, mutation of C121S (a cysteine residue not directly involved in enzyme catalysis<sup><xref ref-type="bibr" rid="CR60">60</xref></sup>) induced no change in Cu<sup>1+</sup> binding stoichiometry (5.6&#x02009;&#x000b1;&#x02009;0.14, <italic>n</italic>&#x02009;=&#x02009;3). Experiments probing Cu<sup>1+</sup> binding by &#x00394;PTPN2 and the corresponding &#x00394;PTPN2 C216S active site mutant (in the presence or absence of 10 protein equivalents of the Cu<sup>1+</sup> chelator glutathione) yielded similar results. In both cases, the &#x00394;PTPN2 Cu<sup>1+</sup>&#x000a0;binding stoichiometry was greater than that of C216S &#x00394;PTPN2 (no glutathione: 1.9&#x02009;&#x000b1;&#x02009;0.16 and 1.8&#x02009;&#x000b1;&#x02009;0.13, respectively; with glutathione: 3.2&#x02009;&#x000b1;&#x02009;0.36 and 3.0&#x02009;&#x000b1;&#x02009;0.24, respectively; <italic>n</italic>&#x02009;=&#x02009;3 for all). The increased Cu<sup>1+</sup> binding stoichiometry in the presence of Cu<sup>1+</sup> chelator may be a consequence of glutathione stabilizing Cu<sup>1+</sup> binding to the protein. We therefore confirmed that copper ions can biochemically modulate PTPN1/2 activity via binding to the catalytic active site cysteine.</p><p id="Par24">We then sought to evaluate specificity of copper&#x000a0;driven PTP inhibition, first relative to the chemically similar, bioavailable metal zinc. We detected no significant increase in CREB nor EGFR phosphorylation following addition of the same concentration of ZnCl<sub>2</sub> as added for CuCl<sub>2</sub> (20&#x02009;&#x000b5;M) (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4c</xref>, Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">19</xref>). Moreover, we found ZnCl<sub>2</sub> supplementation drove weaker activation of <italic>EGR1</italic> expression (and therefore, weaker EGFR activation) than CuCl<sub>2</sub> in A549 cells (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4d</xref>). Indeed, previous studies of multiple cell lines found that while cell membrane&#x000a0;permeable Cu<sup>2+</sup>&#x000a0;complexes induced strong EGFR activation, the Zn<sup>2+</sup>&#x000a0;complexes (or ZnCl<sub>2</sub> supplementation) induced little to no effect<sup><xref ref-type="bibr" rid="CR28">28</xref>,<xref ref-type="bibr" rid="CR61">61</xref></sup>. Thus, PTP inactivation is more sensitive to copper level fluctuations than zinc, particularly in the physiological range of concentrations.</p><p id="Par25">Finally, to confirm that cytosolic copper levels modulate the PTPN2-EGFR pathway, as well as to provide evidence that copper&#x000a0;inhibition of PTPN2 occurs under normal cellular growth conditions, we supplemented A549 cells with chemical probes to directly elevate or depress cytosolic copper levels (bypassing CTR1/DMT1 and intracellular Cu-chaperones). Specifically, we added the copper ionophore Cu-GTSM (which transports Cu<sup>2+</sup> across the plasma membrane and releases Cu<sup>1+</sup> in the cytosol) or the cytosolic copper sensor CS1 (to effectively decrease labile intracellular Cu<sup>1+</sup> levels via binding competition) and assessed changes in EGFR signaling activation via RNA-qPCR (relative to cellular treatment with DMSO control). Four hours after Cu-GTSM supplementation, <italic>EGR1</italic> expression was strongly elevated while <italic>CTR1</italic> levels were decreased even more strongly than CuCl<sub>2</sub>&#x000a0;treatment alone (~25% decrease relative to control, Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4e</xref>). Four hours after CS1 treatment, by contrast, <italic>EGR1</italic> levels significantly decreased, consistent with labile copper driving PTPN2 inhibition under normal cellular growth conditions. For completeness, <italic>CTR1</italic> expression levels were not significantly affected by CS1 treatment.</p><p id="Par26">We then evaluated specificity of copper&#x000a0;driven PTP inhibition relative to general, non-specific PTP inhibition. We compared the CuCl<sub>2</sub>&#x000a0;treated A549 cell proteome profiler antibody array results to signal transduction activation following addition of 20&#x02009;&#x000b5;M pervanadate solution, which serves as a general PTP inhibitor (via oxidation of PTP active site cysteines). While copper supplementation drove significant repression of AKT and p70S6K phosphorylation, presumably indicating repression of mTOR signaling, pervanadate (perhaps unsurprisingly) drove activation of virtually all signaling proteins evaluated (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">20</xref>). Thus, the copper signaling responses elicited by PTPN2&#x000a0;inactivation in A549 cells do not reflect a broad PTP inhibition mechanism, but rather drive more specific signaling activation.</p></sec></sec><sec id="Sec8" sec-type="discussion"><title>Discussion</title><p id="Par27">Toxicological studies assessing ex vivo<sup><xref ref-type="bibr" rid="CR50">50</xref>,<xref ref-type="bibr" rid="CR51">51</xref></sup> and in vitro (cellular)<sup><xref ref-type="bibr" rid="CR44">44</xref>,<xref ref-type="bibr" rid="CR52">52</xref></sup> environmental exposure to aberrant levels of copper proposed metallo-inactivation of the ubiquitous, highly&#x000a0;expressed PTPN1 via an unknown molecular mechanism. The previous literature offers conflicting reports on whether or not low&#x000a0;level copper concentration fluctuations&#x02014;such as occurring under normal, physiological conditions&#x02014;affect this pathway<sup><xref ref-type="bibr" rid="CR28">28</xref>,<xref ref-type="bibr" rid="CR44">44</xref>,<xref ref-type="bibr" rid="CR61">61</xref></sup>. Relatedly, our findings represent two main discoveries.</p><p id="Par28">First, we have identified PTPN2 as a mammalian copper receptor capable of relaying changes in physiological copper levels into signal transduction responses. Regarding the apparent copper&#x000a0;inactivation specificity of PTPN2 over PTPN1, a more comprehensive analysis of <italic>PTP</italic> siRNA knockdowns in MCF7 breast cancer cells also found <italic>PTPN2</italic> knockdown significantly diminished EGFR activation by EGF, while <italic>PTPN1</italic> knockdown had no effect<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>. Cell imaging experiments found PTPN1 localized almost exclusively to the perinuclear region, in contrast to PTPN2, which was more diffuse throughout the cell<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>. Thus, we propose PTPN2 is a more sensitive reporter of changes in imported copper levels due to its more proximal localization near the cell membrane (and membrane&#x000a0;localized EGFR). We therefore assign PTPN2 as the physiological sensor of copper but note that due to the highly homologous nature of PTPN1 and PTPN2, we do not exclude the possibility that PTPN1 can also function in such a role in different cellular contexts. Indeed, following knockdown of <italic>PTPN2</italic>, copper&#x000a0;treatment still stimulated activation of <italic>EGR1</italic> expression, albeit to a lesser extent than without knockdown, reminiscent to similar results reported following <italic>PTPN2</italic> knockdown and EGF activation of EGFR<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>. As receptor tyrosine kinases like EGFR are regulated by a network of PTPs<sup><xref ref-type="bibr" rid="CR48">48</xref>,<xref ref-type="bibr" rid="CR62">62</xref></sup>, this result implies that other EGFR-regulating PTPs may also be susceptible to copper inhibition.</p><p id="Par29">Second, we have established a link between CREB activation and weak <italic>CTR1</italic> transcriptional suppression (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>). Given the super-physiological copper supplementation levels required to drive significant <italic>CTR1</italic> transcriptional repression, it seems implausible that this mechanism exists purely to regulate subtle fluctuations in physiological copper levels, and consequently, our results do not contradict the current mechanistic model that the dominant mechanism of copper&#x000a0;stimulated CTR1 expression regulation occurs at the post-translational level<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>. However, processes such as neuronal differentiation (as modeled by PC12 cells treated with nerve growth factor, NGF) involve strong, sustained CREB activation<sup><xref ref-type="bibr" rid="CR63">63</xref></sup>, substantial intracellular copper accumulation<sup><xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR20">20</xref></sup>, and strong <italic>CTR1</italic> transcriptional repression (via an unknown regulatory mechanism)<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. Thus, we propose CREB activation may be the underlying driver of this <italic>CTR1</italic> repression. Intriguingly, prior studies of PC12 cells have elucidated additional connections between NGF, copper, and CREB: NGF (or at least a peptide corresponding to the NGF N-terminal sequence) can serve as a copper&#x000a0;ionophore, and copper and NGF co-supplementation drives stronger activation of CREB than either component individually<sup><xref ref-type="bibr" rid="CR64">64</xref>,<xref ref-type="bibr" rid="CR65">65</xref></sup>.<fig id="Fig5"><label>Fig. 5</label><caption><title>Schematic representation of copper signaling and <italic>CTR1</italic> repression.</title><p>(top) Proposed mechanism of copper-stimulated EGFR activation, with downstream CREB TF activity and transcriptional repression of <italic>CTR1</italic>. (bottom) Decreased Cu levels result in downregulation of the pathway shown on the top. Figure&#x000a0;5 created with BioRender.com released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license.</p></caption><graphic xlink:href="41467_2024_50524_Fig5_HTML" id="d33e1723"/></fig></p><p id="Par30">The Zn&#x000a0;finger TF SP1 regulates <italic>CTR1</italic> transcription<sup><xref ref-type="bibr" rid="CR66">66</xref></sup>; copper&#x000a0;stimulated changes in <italic>CTR1</italic> transcript levels have been previously reported and attributed to copper&#x000a0;responsive modulation of SP1 TF activity<sup><xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR67">67</xref>&#x02013;<xref ref-type="bibr" rid="CR69">69</xref></sup>. In the reported mechanism, intracellular copper stress drives copper&#x000a0;binding and displacement of Zn<sup>2+</sup> ions from the SP1 zinc fingers<sup><xref ref-type="bibr" rid="CR70">70</xref>,<xref ref-type="bibr" rid="CR71">71</xref></sup>, inhibiting TF activity and thereby lowering <italic>CTR1</italic> (and other SP1 target gene, e.g., <italic>SP1</italic>, <italic>FOXM1</italic>)<sup><xref ref-type="bibr" rid="CR68">68</xref>,<xref ref-type="bibr" rid="CR72">72</xref></sup> expression as SP1 is generally a transcriptional activator<sup><xref ref-type="bibr" rid="CR73">73</xref></sup>. As copper&#x000a0;chelation elevated <italic>CTR1</italic> levels in these studies, the model implies the presence of &#x0201c;copper&#x000a0;substituted&#x0201d; SP1 under normal cellular growth conditions.</p><p id="Par31">However, this model may need to be reconciled with some experimental observations. Namely, copper deficiency in mouse models does not alter <italic>Ctr1</italic> expression levels across multiple organs<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>. Additionally, with over 12,000 SP1 binding sites in the genome<sup><xref ref-type="bibr" rid="CR73">73</xref></sup>, copper&#x000a0;inactivation of SP1 would drive broad repression of many genes unrelated to copper homeostasis (including various housekeeping genes), implying a lack of specificity in the response. Relatedly, in NSCLC cell lines (including A549), SP1 TF activity drives constitutive <italic>VEGF</italic> expression<sup><xref ref-type="bibr" rid="CR74">74</xref></sup>; thus, by the SP1 copper&#x000a0;substitution model, copper stress should suppress <italic>VEGF</italic> expression. By contrast, copper is an established pro-angiogenic factor known to stimulate expression of <italic>VEGF</italic><sup><xref ref-type="bibr" rid="CR75">75</xref></sup>, which we also detected via RNA-seq 4&#x02009;h after super-physiological copper level supplementation (<italic>VEGFA</italic>, Supplementary Data&#x000a0;<xref rid="MOESM6" ref-type="media">3</xref>). Additionally, we found no statistically significant change in <italic>FOXM1</italic> expression levels following copper supplementation at any concentration, while <italic>SP1</italic> expression was significantly increased 4&#x02009;h after super-physiological copper level supplementation. Future work will be required to understand how the model we have established in this report fits with the SP1/<italic>CTR1</italic> regulatory model. It may be that copper&#x000a0;inhibition of PTPN2 and/or SP1 is cellular context dependent: reflective of the relative levels of various Cu<sup>1+</sup>&#x000a0;binding proteins, the level of copper stress, and/or the means through which copper&#x000a0;stress is elicited.</p><p id="Par32">Interestingly, both the pathway reported here and copper&#x000a0;driven inhibition of PDE3B (which leads to elevated cAMP levels, as known to drive CREB activation) converge on cAMP and CREB regulation to connect copper availability with cell growth, proliferation, and differentiation. Finally, EGFR, CREB, and serum/tissue copper depletion are all targets in anti-cancer treatments. Our discovery of a signaling axis involved in <italic>CTR1</italic> repression (a known cause of platinum anticancer drug resistance) represents discovery of a potential targetable axis for synergistic drug efficacy.</p></sec><sec id="Sec9"><title>Methods</title><p id="Par33">Unless otherwise noted, all materials were obtained from ThermoFisher. A549 cells were purchased from ATCC (catalog number: A549 (ATCC&#x000ae; CCL-185&#x02122;)), while HEK 293&#x02009;T were acquired from a lab member who acquired them from ATCC. Cetuximab antibodies were a kind gift from Dr. Bruce Marc Bissonnette. CREB Inhibitor 666-15 was purchased from Sigma-Aldrich and dissolved in DMSO to establish a 17.14&#x02009;mM stock. All volcano plots were generated in RStudio. The term &#x0201c;biological replicate&#x0201d; indicates discrete, separate samples; the same sample was never measured repeatedly. Silencer&#x000ae; Select siRNAs were purchased from ThermoFisher with the following product lot and IDs: PTPN1 (AS02KZQB, s11507), DUSP1 (AS02KZQF, s4363), PTPRG (AS02KZQD, s11549), PTPN2 (AS02KZQC, s11509), MTM1 (AS02KZQH, s9041), PTPRJ (AS02KZQE, s11555), PTEN (AS02KZQG, s536620), CREB1 (AS02JUZ3, s3490), CTR1 (AS02MHH1, s3377), DMT1 (AS02MHH0, s9708), Negative Control #1 siRNA (AS02J03Q, no ID provided).</p><sec id="Sec10"><title>Cell culture</title><p id="Par34">A549 and HEK 293&#x02009;T cells were cultured at 37&#x02009;&#x000b0;C, 5% CO<sub>2</sub>, 90% humidity in CellXpert C170i Cell Culture Incubators. Culture media was Dulbecco&#x02019;s Modified Eagle Medium (DMEM) supplemented with 10% Fetal Bovine Serum (FBS) and 1% Penicillin-Streptomycin (10,000&#x02009;U/mL) (this combined solution is referred to as supplemented-DMEM, sDMEM). Sub-culturing was performed by aspirating the media, washing with an equivalent volume of Dulbecco&#x02019;s phosphate-buffered saline (DPBS), aspirating the DPBS, washing with one-fifth the original media volume 0.25% Trypsin-EDTA, aspirating, incubating for 1&#x02009;min in the cell culture incubator, and then resuspending in sDMEM. Cells were seeded at a 1:4 ratio of cell resuspension solution to fresh sDMEM, and were maintained under 95% confluency. Total sDMEM volume used for 35&#x02009;mm (6 well plate), 100&#x02009;mm, and 150&#x02009;mm Corning cell culture plates was 2&#x02009;mL (per well), 10&#x02009;mL, and 20&#x02009;mL, respectively. Cells were verified mycoplasma negative using the MycoProbe Mycoplasma Detection Kit (R&#x00026;D Systems). For serum-starvation experiments, cell culture sDMEM was replaced with DMEM for times indicated in figures, and cells were subsequently either treated with pre-warmed (to 37&#x02009;&#x000b0;C) DMEM or DMEM supplemented with CuCl<sub>2</sub> at the stated concentrations. For gefitinib/cetuximab treatments, cells were pre-treated with either 2&#x02009;&#x000b5;M gefitinib in sDMEM for 3&#x02009;h or 80&#x02009;&#x003bc;g/mL Cetuximab in sDMEM for 4&#x02009;h in the cell culture incubator. For subsequent Cu-treatment of EGFR-inhibitor pretreated cells: Cu-supplemented, EGFR-inhibitor supplemented (same concentrations) sDMEM was pre-warmed (to 37&#x02009;&#x000b0;C) and subsequently used to replace the cell supernatant media. For Cu-GTSM (Cayman Chemical Company) and CS1 (MedChemExpress) treatments, the solid drugs were dissolved in DMSO to a final concentration of 1&#x02009;mM. 10&#x02009;&#x003bc;L, 100&#x02009;&#x003bc;L, and 100&#x02009;&#x003bc;L of Cu-GTSM, CS1, and DMSO solutions, respectively, were added to 20&#x02009;mL of prewarmed sDMEM. These solutions were then used to replace the cell supernatant media, and the cells were incubated in the cell incubator for 4&#x02009;h before RNA extraction.</p><p id="Par35">MDA-MB-468 cells were cultured by Dr. Olufunmilayo Olopade&#x02019;s group in RPMI-1640 supplemented with 10% FBS and antibiotic-antimycotic solution (Gibco). Cells were handled and treated (with TM- and/or DMSO) as described elsewhere<sup><xref ref-type="bibr" rid="CR76">76</xref></sup>.</p></sec><sec id="Sec11"><title>Pervanadate generation</title><p id="Par36">To generate the pervanadate solution for PTP inhibition, we first generated a fresh stock of 100&#x02009;mM sodium orthovanadate in water. 20&#x02009;&#x003bc;L of this solution was mixed with 23&#x02009;&#x003bc;L 30% H<sub>2</sub>O<sub>2</sub> and 157&#x02009;&#x003bc;L of DMEM, which was then incubated at room temperature (in the dark) for 30&#x02013;45&#x02009;min to prepare a 10&#x02009;mM pervanadate stock. Pervanadate solutions were generated immediately prior to cell treatment.</p></sec><sec id="Sec12"><title>Antibody array and associated imaging</title><p id="Par37">Cells were seeded in 150&#x02009;mm plates and treated at ~80% confluency. Following serum-starvation, supernatant media was removed and replaced with either DMEM or metal-supplemented DMEM. The plates were subsequently put back into the cell culture incubator for the times noted in the text. Cells were harvested, lysed, and lysates assessed with the Proteome Profiler Human Phospho-Kinase Array Kit (R&#x00026;D Systems) and C-Series Human EGFR Phosphorylation Antibody Array 1 Kit (RayBiotech) according to manufacturer protocols. Imaging was conducted with the FluorChem R System; experimental and control membranes were imaged for identical exposure durations to facilitate normalization of chemiluminescence intensities across membranes. Integrated pixel densities were measured in ImageJ (1.53k); pixel densities were subsequently background corrected and normalized to reference control spot-antibody pixel density intensities.</p></sec><sec id="Sec13"><title>ChIP-seq data analysis</title><p id="Par38">ChIP-seq BigWig files were accessed from the ChIP-Atlas database. Wiggletools v1.2.11 was used to calculate the mean of BigWig files as indicated in the text, which was output as a Wig file. Wig files were subsequently converted to BigWig files using the ucsc-wigtobigwig package (v377). BigWig files were visualized using IGV.</p></sec><sec id="Sec14"><title>KAS-seq and data analysis</title><p id="Par39">The KAS-seq labeling and isolation procedure was followed as previously described<sup><xref ref-type="bibr" rid="CR77">77</xref></sup>, with the following changes. Cell culture media was removed and subsequently replaced with CuCl<sub>2</sub>-supplemented (or CuCl<sub>2</sub>-unsupplemented control) sDMEM for times indicated in the volcano plots. Following incubation, 500&#x02009;mM N<sub>3</sub>-kethoxal (in DMSO) stock was added directly to the cell media to a final concentration of 5&#x02009;mM. After addition, the solution was vigorously shaken to promote solvation of the moderately-soluble N<sub>3</sub>-kethoxal. Dual index library construction used an Accel-NGS Methyl-Seq DNA library kit; libraries were sequenced at the Genomics Facility (University of Chicago) via single-end Illumina NovaSeq 6000 (SP flowcell, 100&#x02009;bp cassette) sequencing. Reads from two sequencing runs were catenated, and then processed following the KAS-pipe data processing pipeline<sup><xref ref-type="bibr" rid="CR77">77</xref></sup> (mapped to human genome build hg19) on a Lenovo Thinkstation P920 workstation.</p></sec><sec id="Sec15"><title>RNA extraction and RNA-qPCR</title><p id="Par40">Total RNA was isolated using either TRIzol according to provided instructions, or a combination of TRIzol and the RNA Clean &#x00026; Concentrator-5 (RCC-5) kit (Zymo Research), according to the Zymo instructions for combination Trizol/Zymo-Spin-Column RNA isolation. Samples prepared using the RCC-5 kit were also treated with in-column DNase I following Zymo instructions. cDNA synthesis was performed via either Maxima First Strand cDNA Synthesis Kit for RT-qPCR (with dsDNAse added), or High Capacity cDNA Reverse Transcription Kit (Applied Biosciences). RNA levels were quantified by determining cycle threshold (Ct) values of corresponding cDNAs with the QuantStudio 6 Pro system (Applied Biosciences, A43180) and FastStart Essential DNA Green Master (Roche) at a final concentration of 1X, with ~500&#x02009;nM forward and reverse primers, in a final reaction volume of 20&#x02009;&#x003bc;L per well in MicroAmp Optical 96-Well Reaction Plates (primer sequences provided in Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">4</xref>). Samples were amplified with the following run method: 10&#x02009;min hold at 95&#x02009;&#x000b0;C, 40x cycles of 20&#x02009;s at 95&#x02009;&#x000b0;C, 20&#x02009;s at 60&#x02009;&#x000b0;C, and 20&#x02009;s at 72&#x02009;&#x000b0;C (during which fluorescence measurements occurred), before a final 15&#x02009;s at 95&#x02009;&#x000b0;C and 1&#x02009;min at 60&#x02009;&#x000b0;C. The cycle was completed with a melting curve while measuring fluorescence. All biological replicates comprised at least 2 technical replicates. All transcripts were processed using the 2<sup>-&#x02206;&#x02206;Ct</sup> relative expression normalization method<sup><xref ref-type="bibr" rid="CR78">78</xref></sup>, using <italic>GAPDH</italic> as an internal reference standard.</p><p id="Par41">Copper treatment RNA-qPCR experiments compared metal-treated to control sDMEM-treated values. siRNA treatment experiments compared cDNA generated following experimental siRNA treatment to cDNA generated from Silencer&#x000ae; Select Negative Control No. 1 siRNA-transfected cells. Gefitinib pretreatment experiments compared gefitinib-pretreated, Cu-treated to gefitinib-pretreated cell cDNA. Cu-GTSM and CS1 experiments compared drug treated cell cDNA to DMSO-treated cell cDNA. Two-tailed, paired T-test <italic>p</italic>-values were calculated in RStudio, using the following packages: dplyr v1.0.7, tidyverse v1.3.1, readxl v1.3.1, ggprism v1.0.3. Example code is provided in the Supplementary Materials.</p></sec><sec id="Sec16"><title><italic>CREB1</italic> and <italic>PTP</italic> Knockdown</title><p id="Par42">Knockdown of CREB1 and PTPs was performed via transfection of Silencer Select siRNAs using Lipofectamine&#x02122; RNAiMAX Transfection Reagent. Specifically, cells were seeded in sDMEM lacking antibiotics ~24&#x02009;h prior to transfection to generate 6 well plates in which individual wells were ~40&#x02013;50% confluent at time of treatment. Per cell treatment: 9&#x02009;&#x003bc;L of Lipofectamine was diluted into 150&#x02009;&#x003bc;L of Opti-MEM at room temperature, and separately, 3&#x02009;&#x003bc;L of 10&#x02009;&#x003bc;M siRNA was diluted into 150&#x02009;&#x003bc;L of Opti-MEM. The diluted siRNA was then mixed with the diluted Lipofectamine in a 1:1 ratio, and incubated at room temperature for 5&#x02009;min. 250&#x02009;&#x003bc;L of the Lipofectamine/siRNA mixture was added to the 2&#x02009;mL of cell media in the well, and then quickly mixed back and forth to promote homogenization. Cells were then put back into the cell incubator for 24&#x02009;h prior to treatment and/or RNA extraction and RNA-qPCR measurement.</p></sec><sec id="Sec17"><title>Constitutive CREB expression vector transfection</title><p id="Par43">The CREB Dominant-Negative Vector Set was purchased from Takara Bio, and the vectors subsequently transformed into DH5&#x003b1; Mix and Go! competent <italic>E. coli</italic> (Zymo Research) and plated onto LB-agar plates with 50&#x02009;&#x003bc;g/mL kanamycin and colonies grown overnight at 37 &#x000b0;C. Vector transformed colonies were picked and grown in a 10&#x02009;mL LB culture with 50&#x02009;&#x003bc;g/mL kanamycin (37&#x02009;&#x000b0;C with vigorous shaking). This culture was used to inoculate overnight 1&#x02009;L cultures of LB with 50&#x02009;&#x003bc;g/mL kanamycin (grown at 37&#x02009;&#x000b0;C with vigorous shaking). The plasmid was subsequently purified using a QIAGEN plasmid maxi kit following manufacturer protocol.</p><p id="Par44">A549 cells in antibiotic-free sDMEM were transfected with 2.5&#x02009;&#x003bc;g of purified pCMV-CREB Vector (corresponding to a plasmid for constitutive CREB expression) using a Lipofectamine 3000 reagent kit, following the manufacturer protocol. As a negative control, cells were transfected (following the same procedure) with the DsRed-EGFP in a pcDNA3.1 HisC vector<sup><xref ref-type="bibr" rid="CR79">79</xref></sup>.</p></sec><sec id="Sec18"><title>DMT1 constitutive expression vector transfection and siRNA knockdown</title><p id="Par45">The DMT1/SLC11A2 ORF was cloned into a pcDNA3.1&#x02009;+&#x02009;/C-(K)DYK vector by Genscript. The vector was subsequently transformed into One Shot MAX Efficiency DH5-T1R Competent <italic>E. coli</italic> cells via heat shock and were plated onto Amp100 plates (100&#x02009;&#x003bc;g/mL ampicillin in LB-agar) for antibiotic selection. Vector-transformed <italic>E. coli</italic> colonies were subsequently picked and grown at 37&#x02009;&#x000b0;C in 10&#x02009;mL starter LB-cultures with 100&#x02009;&#x003bc;g/mL ampicillin. This cell suspension was then used to inoculate 600&#x02009;mL of LB media + 100&#x02009;&#x003bc;g/mL ampicillin; this culture was grown with vigorous shaking at 37&#x02009;&#x000b0;C overnight. The plasmid was subsequently purified using a QIAGEN plasmid maxi kit following manufacturer protocol.</p><p id="Par46">A549 cells in antibiotic-free sDMEM (in 6 well plates with 2&#x02009;mL of media) were transfected with 2.5&#x02009;&#x003bc;g of the purified DMT1 vector using a Lipofectamine 3000 reagent kit, following the manufacturer protocol. As a negative control, cells were transfected (following the same procedure) with the DsRed-EGFP in a pcDNA3.1 HisC vector<sup><xref ref-type="bibr" rid="CR79">79</xref></sup>. In parallel, DMT1 Silencer Select siRNA transfections were performed following the same procedure as described for the <italic>CREB1</italic>/<italic>PTP</italic> knockdown. 48&#x02009;h after vector or siRNA transfection, cells were treated with 200&#x02009;&#x003bc;M CuCl<sub>2</sub>. Cells were incubated in the cell incubator for 1&#x02009;h (37&#x02009;&#x000b0;C, 5% CO2, 90%) before RNA extraction and cDNA generation.</p></sec><sec id="Sec19"><title>MDA-MB-468 RNA-seq and data analysis</title><p id="Par47">Total RNA was extracted from MDA-MB-468 cells via Trizol extraction; the RiboMinus Eukaryote Kit was then used according to manufacturer protocol to remove ribosomal RNA. RNA were then used for library construction using a SMARTer Stranded RNA-seq kit (Takara, 634839) according to the manufacturer protocol. Paired-end high-throughput sequencing was subsequently performed at the University of Chicago Genomics Facility on an Illumina HiSeq 4000 sequencer.</p><p id="Par48">Reads were trimmed using the KAS-pipe paired-end trim_adapter.sh script. Trimmed reads were aligned to STAR reference genomes (using STAR version 2.7.9a) generated from the human genome build hg38. Aligned reads were then processed to remove (i) rows &#x0201c;N_ambig&#x0201d;, &#x0201c;N_multima&#x0201d;, and &#x0201c;N_noFeat&#x0201d; and (ii) transcripts with 2 or fewer average read counts. Unstranded column reads were then processed for differential expression analysis via DESeq2 v1.36.0. Pathway/process enrichment analysis of significantly differentially-expressed transcripts was performed via Metascape<sup><xref ref-type="bibr" rid="CR80">80</xref></sup>, while GSEA was performed using GSEA v4.2.3.</p></sec><sec id="Sec20"><title>A549 RNA-seq and data analysis</title><p id="Par49">Total RNA was isolated using a combination of TRIzol and the RCC-5 kit (Zymo Research), according to Zymo&#x02019;s instructions for combination Trizol/Zymo-Spin-Column RNA isolation. Samples prepared using the RCC-5 kit were also treated with in-column DNase I according to provided Zymo instructions. Total isolated RNA was subjected to two rounds of poly(A)-enrichment using the Dynabeads mRNA DIRECT Kit according to the manufacturer&#x02019;s instructions twice on each sample.</p><p id="Par50">Library preparation was performed with 5&#x02009;&#x000b5;L of twice poly(A)-enriched sample using the NEBNext Ultra II Directional RNA Library Prep Kit for Illumina (New England BioLabs) according to manufacturer&#x02019;s instructions for &#x0201c;Protocol for use with Purified mRNA or rRNA Depleted RNA&#x0201d;. Paired-end high throughput sequencing was subsequently performed on an Illumina NextSeq 550. FastQ files from each sample across runs were subsequently combined. Adapter trimming and basic QC was carried out with Trim Galore. Alignment to the human hg38 reference genome was carried out with HISAT2 (v2.2.1). Duplicate read removal was carried out with Samtools (v1.13). Transcript identification and read counting was performed with featureCounts according to gene transfer format files provided by release 107 of the Ensembl database.</p><p id="Par51">Transcripts with fewer than 0.74 average reads per replicate across all samples were excluded from analysis. Differential expression analysis was performed by the DESeq2 R package DESeq2 v1.34.0. Pathway/process enrichment analysis of significantly differentially-expressed transcripts was performed via Metascape<sup><xref ref-type="bibr" rid="CR80">80</xref></sup>.</p></sec><sec id="Sec21"><title>TCGA and GTEx RNA-seq data analysis</title><p id="Par52">Lung adenocarcinoma (LUAD) TCGA data was accessed via the Xenabrowser server<sup><xref ref-type="bibr" rid="CR81">81</xref></sup>&#x02014;transcript read counts were converted from &#x0201c;log<sub>2</sub>(norm count + 1)&#x0201d; to &#x0201c;norm count + 1&#x0201d; prior to statistical analysis. <italic>p</italic>-values were generated in Excel via the t-Test: Two-Sample Assuming Unequal Variances function.</p><p id="Par53">GTEx Analysis V8 release gene read counts were downloaded from the GTEx Portal. Read counts were first separated by tissue into discrete datasets, which were subsequently processed and analyzed separately. Next, transcripts with 2 or fewer average read counts were removed. Next, differential expression analysis (comparing tissue samples against an arbitrarily chosen sample from the same tissue) via DESeq2 v1.36.0 was performed to generate normalized read counts. Transcript correlations and plots (as well as associated statistical analysis) were subsequently generated in RStudio from the DESeq2 normalized read counts using ggpubr v0.4.0. Example code is provided in the Supplementary Materials.</p></sec><sec id="Sec22"><title>Cloning and expression of sEGFR</title><p id="Par54">Recombinant human EGFR extracellular domain (residues 1-642) was expressed in insect cells as secreted protein using an approach described previously<sup><xref ref-type="bibr" rid="CR82">82</xref></sup>. Briefly, human EGFR extracellular domain (residues 1-642) followed by an HRV3C cleavage site and a C-terminal 6x-histidine tag was subcloned into a pVL1393 vector. To generate the baculovirus, the constructed plasmid was co-transfected with the linearized baculovirus DNA (Expression Systems, 91-002) using Cellfectin II (Thermo Fisher, 10362100). Baculovirus was subsequently amplified in Sf9 cells (Thermo Fisher, 12659017) cultured in Sf-900 III SFM medium (Gibco, 12658019), supplemented with 10% heat-inactivated fetal bovine serum (Cityva, SH30396), 2 mM L-Glutamine (Cityva, SH3003402), and 10&#x02009;&#x003bc;g/mL gentamicin at 27&#x02009;&#x000b0;C. Large-scale protein expression was performed by infection of High-Five cells (Thermo Fisher, B85502) in Insect-XPRESS medium (Lonza, BELN12-730Q) medium at a cell density of 2.0&#x02009;&#x000d7;&#x02009;10<sup>6</sup> cells/ml for 64 to 70&#x02009;h at 27&#x02009;&#x000b0;C.</p></sec><sec id="Sec23"><title>Purification of sEGFR</title><p id="Par55">The EGFR signal peptide (residues 1&#x02013;24) was cleaved after secretion. The medium containing secreted EGFR (25&#x02013;642) was collected and centrifuged at 900&#x02009;&#x000d7;&#x02009;<italic>g</italic> for 15&#x02009;min at room temperature. The supernatant was transferred into a beaker and mixed with buffer and salt reagents; the final mixture contained 50&#x02009;mM Tris, pH 8.0, 5&#x02009;mM CaCl<sub>2</sub> and 1&#x02009;mM NiCl<sub>2</sub>. The mixture was stirred at 130&#x02009;rpm for 30&#x02009;min at room temperature. After a centrifugation (8000&#x02009;&#x000d7;&#x02009;<italic>g</italic>, 30&#x02009;min), the cleared supernatant was incubated with Ni-NTA resin (Thermo Scientific, 88223) for 4&#x02009;h at room temperature. The resin was collected using a glass Buchner funnel and rinsed with HBS buffer (10&#x02009;mM HEPES, pH 7.2, 150&#x02009;mM NaCl) containing 10&#x02009;mM imidazole, before transferring to a gravity column (Bio-Rad, 7372512). The protein was eluted with HBS buffer containing 200&#x02009;mM imidazole. The eluent was concentrated and further purified by size-exclusion chromatography (Superdex 200 10/300 GL; GE Healthcare) equilibrated in a buffer containing 20&#x02009;mM HEPES, pH 7.5 and 100&#x02009;mM NaCl. Cleavage of the His-tag by HRV3C protease (Takara, 7360) followed the manufacturer&#x02019;s protocol. HRV3C protease and cleaved His-tag were removed from sEGFR by a second size-exclusion chromatography (Superdex 200 10/300 GL) run. Purified sEGFR with or without His-tag were validated by western blot (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">21</xref>) and successful removal of His-tag was observed in HRV3C protease treated sEGFR using the anti-His-tag antibody (Genscript, A00186-100) at a final concentration of 0.5&#x02009;&#x003bc;g/mL.</p></sec><sec id="Sec24"><title>Phen green competition experiments</title><p id="Par56">For fluorescence measurements, 1&#x02009;mg aliquots of Phen Green were dissolved in 472&#x02009;&#x003bc;L of DMSO&#x02014;from this stock, a 3&#x02009;&#x003bc;M Phen Green stock in 20&#x02009;mM HEPES, 100&#x02009;mM NaCl, pH 7.5 was prepared. Invitrogen 96-well Fluorescence-based Assay Microplate wells were filled with 600&#x02009;&#x003bc;L of either (i) 20&#x02009;mM HEPES, 100&#x02009;mM NaCl, pH 7.5 buffer control, (ii) 3.64&#x02009;&#x003bc;M sEGFR, 1&#x02009;&#x003bc;M Phen Green (dissolved in DMSO) in 20&#x02009;mM HEPES, 100&#x02009;mM NaCl, pH 7.5, and (iii) 3.64&#x02009;&#x003bc;M sEGFR, 1&#x02009;&#x003bc;M Phen Green in DMSO in 20&#x02009;mM HEPES, 100&#x02009;mM NaCl, pH 7.5 with a screen of CuCl<sub>2</sub> concentrations (denoted in the respective figures) ranging from 0 equivalents (relative to Phen Green) to 1 equivalent. Fluorescence measurements were performed on a Synergy HTX Multi-Mode Reader, using an excitation wavelength of 485&#x02009;nm and an emission wavelength of 528&#x02009;nm (with the optics in the top position). Following measurement, to all wells 3&#x02009;&#x003bc;L of 5&#x02009;&#x003bc;M CuCl<sub>2</sub> in 20&#x02009;mM HEPES, 100&#x02009;mM NaCl, pH 7.5 were added; samples were then incubated at room temperature for 15&#x02009;min prior to subsequent fluorescence measurement. &#x00394;<sub>Fluorescence</sub> titration curves were then generated by averaging 5 measurements for each CuCl<sub>2</sub> titration concentration, and defining the 0&#x02009;&#x003bc;M CuCl<sub>2</sub> added measurement as &#x0201c;0&#x0201d; and the lowest fluorescence intensity measurement as &#x0201c;1&#x0201d;. Curve fitting was performed using the Matlab Curve Fitting App to the equation <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\triangle }_{{{\rm{Fluorescence}}}}=\frac{{{{\rm{B}}}}_{\max }[{{{\rm{CuCl}}}}_{2}]}{{{{{\rm{K}}}}_{{{\rm{D}}}}}^{{{\rm{app}}}}+[{{{\rm{CuCl}}}}_{2}]}$$\end{document}</tex-math><mml:math id="M2"><mml:msub><mml:mrow><mml:mo>&#x025b3;</mml:mo></mml:mrow><mml:mrow><mml:mi mathvariant="normal">Fluorescence</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">B</mml:mi></mml:mrow><mml:mrow><mml:mi>max</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">CuCl</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">K</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi mathvariant="normal">app</mml:mi></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">CuCl</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:mrow></mml:mfrac></mml:math><inline-graphic xlink:href="41467_2024_50524_Article_IEq1.gif"/></alternatives></inline-formula>, where [CuCl<sub>2</sub>] corresponds to the added concentration of CuCl<sub>2</sub> in 20&#x02009;mM HEPES, 100&#x02009;mM NaCl, pH 7.5, B<sub>max</sub> corresponds to the number of Cu binding sites on the protein, and K<sub>D</sub><sup>app</sup> is the apparent Phen Green K<sub>D</sub> (corresponding to the true Phen Green KD when [sEGFR] = 0, assuming negligible Cu<sup>2+</sup> binding by the buffer) This value was used to determine the sEGFR Cu<sup>2+</sup> as described below.</p><p id="Par57">We first assumed that there was no &#x0201c;free&#x0201d; solution Cu<sup>2+</sup>: all Cu<sup>2+</sup> added to the solution was bound by sEGFR or Phen Green. Then, from the equation <inline-formula id="IEq2"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\frac{\left[{{\rm{ML}}}\right][{{\rm{P}}}]}{\left[{{\rm{MP}}}\right][{{\rm{L}}}]}=\frac{{{{\rm{K}}}}_{{{\rm{D}}}({{\rm{P}}})}}{{{{\rm{K}}}}_{{{\rm{D}}}({{\rm{L}}})}}$$\end{document}</tex-math><mml:math id="M4"><mml:mfrac><mml:mrow><mml:mfenced close="]" open="["><mml:mrow><mml:mi mathvariant="normal">ML</mml:mi></mml:mrow></mml:mfenced><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mi mathvariant="normal">P</mml:mi></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mfenced close="]" open="["><mml:mrow><mml:mi mathvariant="normal">MP</mml:mi></mml:mrow></mml:mfenced><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mi mathvariant="normal">L</mml:mi></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">K</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi mathvariant="normal">P</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">K</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi mathvariant="normal">L</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:math><inline-graphic xlink:href="41467_2024_50524_Article_IEq2.gif"/></alternatives></inline-formula>; where [ML], [P], [MP], and [L] correspond to the Phen Green-bound Cu<sup>2+</sup>, apo-sEGFR, sEGFR-bound Cu<sup>2+</sup>, and apo-Phen Green concentrations, respectively, while K<sub>D(P)</sub> and K<sub>D(L)</sub> are the Cu<sup>2+</sup> K<sub>D</sub> values for sEGFR and Phen Green, respectively; [L] = [ML] when [MP] = K<sub>D</sub><sup>app</sup> (this is just a substitution of [MP] for &#x0201c;free&#x0201d; solution Cu<sup>2+</sup>, or [M] in this case, into the definition of K<sub>D</sub>). Consequently, when [MP] = K<sub>D</sub><sup>app</sup>, the equation may be simplified to <inline-formula id="IEq3"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\frac{[{{\rm{P}}}]}{\left[{{\rm{MP}}}\right]}=\frac{{{{\rm{K}}}}_{{{\rm{D}}}({{\rm{P}}})}}{{{{\rm{K}}}}_{{{\rm{D}}}({{\rm{L}}})}}$$\end{document}</tex-math><mml:math id="M6"><mml:mfrac><mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mi mathvariant="normal">P</mml:mi></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mfenced close="]" open="["><mml:mrow><mml:mi mathvariant="normal">MP</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">K</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi mathvariant="normal">P</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">K</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi mathvariant="normal">L</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:math><inline-graphic xlink:href="41467_2024_50524_Article_IEq3.gif"/></alternatives></inline-formula> or <inline-formula id="IEq4"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\frac{[{{\rm{P}}}]}{{{{{\rm{K}}}}_{{{\rm{D}}}}}^{{{\rm{app}}}}}=\frac{{{{\rm{K}}}}_{{{\rm{D}}}({{\rm{P}}})}}{{{{\rm{K}}}}_{{{\rm{D}}}({{\rm{L}}})}}$$\end{document}</tex-math><mml:math id="M8"><mml:mfrac><mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mi mathvariant="normal">P</mml:mi></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">K</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi mathvariant="normal">app</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">K</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi mathvariant="normal">P</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">K</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi mathvariant="normal">L</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:math><inline-graphic xlink:href="41467_2024_50524_Article_IEq4.gif"/></alternatives></inline-formula>. From this equation, we calculated K<sub>D(P)</sub>.</p></sec><sec id="Sec25"><title>ICP-MS</title><p id="Par58">Metal-bound protein solutions (sEGFR, &#x00394;PTPN1 and associated mutant, &#x00394;PTPN2 and associated mutant) were precipitated to release bound metals via addition of 5% HNO<sub>3</sub>. The protein precipitate was subsequently pelleted by centrifugation. Sample measurements were performed via an Agilent 7700x ICP-MS in He mode, and were subsequently analyzed using ICP-MS Mass Hunter version B01.03. Intensities were correlated to ppb concentrations using multi-element ICP-MS standards (Inorganic Ventures).</p></sec><sec id="Sec26"><title>EPR spectroscopy</title><p id="Par59">For EPR measurements, ~200&#x02009;&#x003bc;L of ~100&#x02013;200&#x02009;&#x003bc;M sEGFR was aliquoted into Wilmad quartz X-band EPR tubes and flash frozen in liquid nitrogen. X-band continuous wave (CW) EPR measurements were performed at both the University of Chicago using a Bruker Elexsys E500 spectrometer featuring an Oxford ESR 900 X-band cryostat with a Bruker Cold-Edge Stinger.</p></sec><sec id="Sec27"><title>Mass photometry</title><p id="Par60">Mass photometry experiments were conducted at the University of Illinois at Chicago campus (Biophysics Core), using a Refeyn Two Mass Photometer (Refeyn Ltd, Oxford, UK). Data acquisition and processing were performed using Acquire MP software and DiscoverMP software, respectively. sEGFR in 20&#x02009;mM HEPES, 100&#x02009;mM NaCl, pH 7.5 (final concentration of 100&#x02009;nM) were incubated overnight at 4&#x02009;&#x000b0;C with the indicated concentrations of CuCl<sub>2</sub> (in 20&#x02009;mM HEPES, 100&#x02009;mM NaCl, pH 7.5) or 20&#x02009;mM HEPES, 100&#x02009;mM NaCl, pH 7.5 buffer as a control. 10&#x02009;&#x003bc;L of protein sample was then mixed with 10&#x02009;&#x003bc;L of 20&#x02009;mM HEPES, 100&#x02009;mM NaCl, pH 7.5 buffer on the sample well cassette before immediately beginning the measurement. Ratiometric contrast to mass conversion was performed by comparison to Thyroglobulin (TG) and beta-amylase (BAM) provided by the University of Illinois at Chicago Biophysics Core.</p></sec><sec id="Sec28"><title>Cloning and expression of &#x00394;PTPN1/2 constructs</title><p id="Par61">The &#x00394;PTPN1, C215S &#x00394;PTPN1, &#x00394;PTPN2, and C216S &#x00394;PTPN2 constructs were cloned into a pET-28a(+)-TEV vector, featuring C-terminal TEV protease cleavage site followed by (His)<sub>6</sub>-tag, by Genscript. The C121S &#x00394;PTPN1 mutant was generated from the &#x00394;PTPN1 vector using a QuikChange II Site Directed Mutagenesis kit (Agilent), and the mutant sequence verified by whole plasmid sequencing (Azenta). Vectors were transformed into BL21 Star (DE3) <italic>E. coli</italic> via heat shock and were plated onto Kan50 plates (50&#x02009;&#x003bc;g/mL kanamycin in LB-agar) for antibiotic selection. Vector-transformed <italic>E. coli</italic> colonies were subsequently picked and grown at 37&#x02009;&#x000b0;C in 10&#x02009;mL overnight starter LB-cultures with 50&#x02009;&#x003bc;g/mL kanamycin. After overnight growth, 3&#x02009;mL of cell suspension was used to inoculate 1&#x02009;L of LB media + 50&#x02009;&#x003bc;g/mL kanamycin. This culture was grown with vigorous shaking at 37&#x02009;&#x000b0;C until the culture reached an OD<sub>600</sub> of ~0.5, at which point IPTG was added to a final concentration of 200&#x02009;&#x003bc;M and the cell culture temperature was lowered to 15&#x02009;&#x000b0;C. Following overnight protein expression, the cells were pelleted by centrifugation (4&#x02009;&#x000b0;C, 5000&#x02009;&#x000d7;&#x02009;<italic>g</italic>, 10&#x02009;min) and the supernatant poured off. Cell pellets were subsequently frozen in liquid nitrogen, and stored at &#x02212;80 &#x000b0;C.</p><p id="Par62">~10&#x02009;g cell pellets were thawed and resuspended in 50&#x02009;mL pre-chilled cell lysis buffer (100&#x02009;mM Tris-HCl pH 7.5, 100&#x02009;mM NaCl, 10&#x02009;mM BME, 5% glycerol) and lysed via sonication. After sonication, the cell solution was moved to a 50&#x02009;mL conical tube and the cell remains were pelleted by centrifugation (4&#x02009;&#x000b0;C, 30&#x02009;min, 10,000&#x02009;&#x000d7;&#x02009;<italic>g</italic>). The supernatant was moved to a new 50&#x02009;mL conical tube and again cleared by centrifugation (4&#x02009;&#x000b0;C, 30&#x02009;min, 10,000&#x02009;&#x000d7;&#x02009;<italic>g</italic>). The supernatant was moved to a new 50&#x02009;mL conical tube and held on ice. 2&#x02009;mL of HisPur Ni-NTA Resin per 10&#x02009;g cell pellet were washed repeatedly with column buffer (100&#x02009;mM Tris-HCl pH 7.5, 100&#x02009;mM NaCl, 10&#x02009;mM BME, 10&#x02009;mM imidazole) and resuspended to a final volume of 2&#x02009;mL with column buffer. The resin was then added to the cleared cell supernatant in lysis buffer, and the supernatant solution was subsequently gently mixed at room temperature for 30&#x02009;min. After 30&#x02009;min, removed supernatant solution and washed 5x with column buffer (beads were centrifuged for 2&#x02009;min, 4&#x02009;&#x000b0;C, 700&#x02009;&#x000d7;&#x02009;<italic>g</italic>, supernatant removed, and beads resuspended with column buffer). After the final wash, removed the supernatant solution was removed and 10&#x02009;mL of elution buffer (100&#x02009;mM Tris-HCl pH 7.5, 100&#x02009;mM NaCl, 10&#x02009;mM BME, 500&#x02009;mM imidazole) was added. The beads were incubated on ice for 10&#x02013;15&#x02009;min with gentle periodic resuspension, and then were centrifuged (2&#x02009;min, 4&#x02009;&#x000b0;C, 700&#x02009;&#x000d7;&#x02009;<italic>g</italic>). The supernatant solution containing the eluted protein was set aside, and the elution buffer wash and centrifugation repeated. The eluted protein was then stored at 4&#x02009;&#x000b0;C overnight or was used immediately in the following step.</p><p id="Par63">The eluted protein was subsequently concentrated using an Amicon 3000&#x02009;kDa cutoff spin filters via centrifugation (4&#x02009;&#x000b0;C, 4000&#x02009;&#x000d7;&#x02009;<italic>g</italic>). Following concentration, the protein was buffer exchanged into buffer II (100&#x02009;mM Tris-HCl pH 7.5, 100&#x02009;mM NaCl, 10&#x02009;mM TCEP-HCl) using a PD-10 desalting column. To the eluted protein fractions, 25&#x02009;&#x003bc;L of (His)<sub>6</sub>-tagged TEV-protease (Sigma-Aldrich) was added and the solution incubated overnight at 4&#x02009;&#x000b0;C.</p><p id="Par64">After overnight incubation, ~1.5&#x02009;mL of HisPur Ni-NTA Resin per protein elution was washed and resuspended in buffer II. The resin was then added to the TEV-protease cleaved protein solution to remove the TEV-protease as well as the cleaved (His)<sub>6</sub>-tag. The solution was incubated at 4&#x02009;&#x000b0;C with periodic, gentle mixing for 30&#x02009;min, and the beads were then pelleted by centrifugation (4&#x02009;&#x000b0;C, 4000&#x02009;&#x000d7;&#x02009;<italic>g</italic>). The supernatant containing the purified, (His)<sub>6</sub>-tag-cleaved protein was put into a new tube, and the protein concentration determined by nanodrop (assuming an extinction coefficient of &#x003b5;<sub>Molar</sub>&#x02009;=&#x02009;46410&#x02009;M<sup>&#x02212;1</sup>cm<sup>&#x02212;1</sup> for &#x00394;PTPN1 constructs and &#x003b5;<sub>Molar</sub>&#x02009;=&#x02009;50880&#x02009;M<sup>&#x02212;1</sup>cm<sup>&#x02212;1</sup> for &#x00394;PTPN2 constructs. The protein solutions were moved into 1&#x02009;mL aliquots in 1.5&#x02009;mL Eppendorf tubes, which were flash frozen in liquid nitrogen and stored at &#x02212;80&#x02009;&#x000b0;C.</p></sec><sec id="Sec29"><title>&#x00394;PTPN1 construct Cu<sup>1+</sup> binding assay</title><p id="Par65">To evaluate Cu<sup>1+</sup> binding by the &#x00394;PTPN1 constructs, the purified, (His)<sub>6</sub>-tag-cleaved protein was thawed on ice and diluted with buffer II to a final concentration of 35&#x02009;&#x003bc;M. To generate Cu<sup>1+</sup>, we used an adapted method from Padilla-Benavides et al.<sup><xref ref-type="bibr" rid="CR83">83</xref></sup>. Specifically, CuCl<sub>2</sub> solutions were prepared at the indicated concentrations in buffer II with 100&#x02009;mM sodium ascorbate included as well, to fully reduce the Cu<sup>2+</sup> to Cu<sup>1+</sup>. 500&#x02009;&#x003bc;L of protein solution was mixed with 500&#x02009;&#x003bc;L of 350&#x02009;&#x003bc;M CuCl<sub>2</sub> in buffer II with 100&#x02009;mM sodium ascorbate; the solution was incubated on ice for 1&#x02009;h. After 1&#x02009;h, the solution was run over a PD-10 desalting column (held at 4&#x02009;&#x000b0;C) equilibrated with buffer II. The eluted sample was then used to prepare ICP-MS samples.</p></sec><sec id="Sec30"><title>&#x00394;PTPN2 construct Cu<sup>1+</sup> binding</title><p id="Par66">The purified &#x00394;PTPN2 and &#x00394;PTPN2 C216S proteins were thawed on ice, and then moved to room temperature. To each, either buffer II or 10 protein equivalents of glutathione in buffer II was added. Cu<sup>1+</sup> (in the form of tetrakis(acetonitrile)copper tetrafluoroborate) was dissolved in neat acetonitrile. 5 protein equivalents of Cu<sup>1+</sup> were then added to the 6.6&#x02009;&#x003bc;L of this stock solution was then added to the 660&#x02009;&#x003bc;L solution of protein (or protein with glutathione) for a final Cu1+ concentration of 5 protein equivalents. This mixture was allowed to incubate at room temperature for 15&#x02009;min, before being run over a PD-10 desalting column. The protein concentration was then measured by nanodrop, and the samples were immediately used to generate ICP-MS samples.</p></sec><sec id="Sec31"><title>&#x00394;PTPN1 <italic>p</italic>-Nitrophenyl Phosphate (<italic>p</italic>NPP) Assay</title><p id="Par67">To assess PTP activity of the &#x00394;PTPN1 construct, 100&#x02009;nM purified, His-tag cleaved &#x00394;PTPN1 was aliquoted into a 96 well plate and incubated for 15&#x02009;min with Cu<sup>1+</sup> solution (generated the same as in the &#x00394;PTPN1 Construct Cu<sup>1+</sup> Binding Assay) at room temperature. 20&#x02009;&#x003bc;L of 500&#x02009;mM <italic>p</italic>NPP (New England Biolabs) was then added to the 190&#x02009;&#x003bc;L protein mixture (per well) to generate a final concentration of 47.62&#x02009;mM PNPP per reaction. This mixture was immediately monitored (with a Synergy HTX Multi-Mode Reader plate reader) for the absorbance at 405&#x02009;nm, corresponding to the chromogenic product. All readings were normalized to the initial measurement for each replicate.</p></sec><sec id="Sec32"><title>Statistics and reproducibility</title><p id="Par68">Sample size: For all experiments except RNA-qPCR, experimental sample sizes were pre-determined to be performed in triplicate (or duplicate in the case of KAS-seq) so as to be able to evaluate statistical significance and identify any outlier/anomalous replicates. KAS-seq experiments were performed in duplicate due to the cost-prohibitive nature of the overall experiment. These sample sizes are both sufficient to run advanced analysis (e.g., GSEA on RNA-seq samples), while minimizing false positives in the KAS-seq data (e.g., only two &#x0201c;hits&#x0201d; at 15&#x02009;min post Cu-supplementation). The RNA-qPCR sample sizes were initially envisioned as two biological replicates at each condition (enough for detection of dose-response and statistical significance in changes), but as the experiment evolved and transcripts of interest were added/removed, the previously chosen transcripts (<italic>EGR1</italic>, <italic>CTR1</italic>, <italic>NAB1</italic>, and <italic>NAB2</italic>) were repeatedly evaluated as well. In the case of RNA-qPCR results, the replicates are enough for both statistical significance and to identify trends (such as dose-response) across the Cu supplementation concentrations. Additionally, more biological replicates were performed in response to reviewer comments during a prior journal submission. No statistical method was predetermined before-hand to define sample sizes.</p><p id="Par69">Data exclusions: 1 out of 2 total biological replicates each of <italic>NAB1</italic> and <italic>NAB2</italic> RNA-qPCR (0&#x02013;200&#x02009;&#x003bc;M CuCl<sub>2</sub>, 60&#x02009;min incubation) were excluded for being anomalous; the replicate fold-changes were &#x0003e;3 standard deviations above the mean. 1 out of 22 total biological replicates of <italic>CTR1</italic> (30&#x02013;100&#x02009;uM CuCl<sub>2</sub>, 4&#x02009;h incubation) was excluded for being anomalous; the biological replicate fold-changes were &#x0003e;3 standard deviations above the mean for multiple transcript conditions. The exclusion criteria were not pre-established. Inclusion of the <italic>NAB1</italic>, <italic>NAB2</italic>, and <italic>CTR1</italic> 100&#x02009;&#x003bc;M CuCl<sub>2</sub> data points would not affect any conclusions in the manuscript. Inclusion of the <italic>CTR1</italic> 4&#x02009;h incubation 30&#x02009;&#x003bc;M CuCl<sub>2</sub> would result in the 4&#x02009;h, 30&#x02009;&#x003bc;M CuCl<sub>2</sub>
<italic>CTR1</italic> fold-change increase being statistically significant but would otherwise not affect any of the conclusions in the manuscript.</p><p id="Par70">Replication: All replicates used to derive our conclusions are reported in the manuscript, and were successful in validating the conclusions stated therein.</p></sec><sec id="Sec33"><title>Reporting summary</title><p id="Par71">Further information on research design is available in the&#x000a0;<xref rid="MOESM9" ref-type="media">Nature Portfolio Reporting Summary</xref> linked to this article.</p></sec></sec><sec id="Sec34" sec-type="supplementary-material"><title>Supplementary information</title><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41467_2024_50524_MOESM1_ESM.pdf"><caption><p>Supplementary Information</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="41467_2024_50524_MOESM2_ESM.pdf"><caption><p>Peer Review File</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="41467_2024_50524_MOESM3_ESM.pdf"><caption><p>Description of Additional Supplementary Files</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="41467_2024_50524_MOESM4_ESM.xlsx"><caption><p>Supplementary Data 1</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM5"><media xlink:href="41467_2024_50524_MOESM5_ESM.csv"><caption><p>Supplementary Data 2</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM6"><media xlink:href="41467_2024_50524_MOESM6_ESM.xlsx"><caption><p>Supplementary Data 3</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM7"><media xlink:href="41467_2024_50524_MOESM7_ESM.csv"><caption><p>Supplementary Data 4</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM8"><media xlink:href="41467_2024_50524_MOESM8_ESM.csv"><caption><p>Supplementary Data 5</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM9"><media xlink:href="41467_2024_50524_MOESM9_ESM.pdf"><caption><p>Reporting Summary</p></caption></media></supplementary-material>
</p></sec><sec id="Sec35" sec-type="supplementary-material"><title>Source data</title><p>
<supplementary-material content-type="local-data" id="MOESM10"><media xlink:href="41467_2024_50524_MOESM10_ESM.xlsx"><caption><p>Source Data</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p><bold>Change history</bold></p><p>2/27/2025</p><p id="Par1">This article was originally published under a CC BY-NC-ND 4.0 license, but has now been made available under a Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. license. The PDF and HTML versions of the paper have been modified accordingly.</p></fn></fn-group><sec><title>Supplementary information</title><p>The online version contains supplementary material available at 10.1038/s41467-024-50524-5.</p></sec><ack><title>Acknowledgements</title><p>This work was supported by funding from the National Institutes of Health (R01ES030546 and HG006827) to C.H., R35GM143052 to M.Z., K99ES034084 to M.O.R., the Breast Cancer Research Foundation FP049439 to O.I.O., and University of Chicago Yen Postdoctoral Fellowship to M.O.R. We appreciate the kind support from UChicago genomics facility, Mass Spectrometry Facility, and ARC, especially Dr. C. Jin Qin and Dr. Pieter W. Faber for assisting in the experiments. C.H. is an Investigator of the Howard Hughes Medical Institute. The authors are grateful to Prof. Bruce Marc Bissonnette for the providing Cetuximab antibodies as a kind gift. We thank Prof. Wenbin Lin and Yingjie Fan (University of Chicago) for running the ICP-MS samples, and we thank Prof. Eugene Chang for the use of the anaerobic glovebox.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>Conceptualization: M.O.R. and C.H.; methodology: M.O.R., Y.X., M.Z., and C.H.; investigation: M.O.R., Y.X., R.O., C.Y., O.N. P.Z., R.L., T.W., P.W., and O.K.; funding acquisition: M.O.R., L.L., M.Z., and C.H.; supervision: O.I.O., M.Z., and C.H.; Writing&#x02014;original draft: M.O.R., Y.X., and R.O.; Writing&#x02014;review &#x00026; editing: M.O.R., C.Y., L.L., M.Z., and C.H.</p></notes><notes notes-type="peer-review"><title>Peer review</title><sec id="FPar1"><title>Peer review information</title><p id="Par72"><italic>Nature Communications</italic> thanks Yang Sun and the other, anonymous, reviewers for their contribution to the peer review of this work. A peer review file is available.</p></sec></notes><notes notes-type="data-availability"><title>Data availability</title><p>The high throughput sequencing data generated in this study have been deposited in the Gene Expression Omnibus (GEO), accession <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE211339">GSE211339</ext-link> (A549 KAS-seq), <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE210777">GSE210777</ext-link> (MDA-MB-468 RNA-seq), and <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE214566">GSE214566</ext-link> (A549 RNA-seq). DESeq2 differential expression analysis results from the various KAS-seq and RNA-seq experiments are provided as Supplementary Data&#x000a0;<xref rid="MOESM4" ref-type="media">1</xref> (A549 KAS-seq), 2 (MDA-MB-468 RNA-seq), and 3 (A549 RNA-seq). Metascape gene ontology (GO) enrichment analysis summaries are provided as Supplementary Data&#x000a0;<xref rid="MOESM7" ref-type="media">4</xref> (MDA-MB-468 TM-treated) and 5 (2&#x02009;h, 30&#x02009;&#x000b5;M CuCl2 treated A549 RNA-seq). Specifically, raw qPCR data (fold-changes), ICP-MS Cu-stoichiometries, and pNPP Assay absorbance readings are included in the Source Data file. Raw mass photometry movies are available via Figshare with the following DOI; 10&#x02009;nM TG 10.6084/m9.figshare.26058631.v1; 50&#x02009;nM TG 10.6084/m9.figshare.26058622.v1; 10&#x02009;nM BAM 10.6084/m9.figshare.26058643.v1; 50&#x02009;nM BAM 10.6084/m9.figshare.26058640.v1; sEGFR with buffer added 10.6084/m9.figshare.26058637.v1; sEGFR with 1 equivalent of CuCl<sub>2</sub> added 10.6084/m9.figshare.26058634.v1; sEGFR with 10 equivalents of CuCl<sub>2</sub> 10.6084/m9.figshare.26058628.v1; sEGFR with 100 equivalents of CuCl<sub>2</sub> added 10.6084/m9.figshare.26058625.v1. GTEx and TCGA RNA-seq data were accessed from, and are available via, <ext-link ext-link-type="uri" xlink:href="https://gtexportal.org/home/">https://gtexportal.org/home/</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://xenabrowser.net/">https://xenabrowser.net/</ext-link>, respectively. ChIP-Atlas ChIP-seq data are available via <ext-link ext-link-type="uri" xlink:href="https://chip-atlas.org/">https://chip-atlas.org/</ext-link>. CREB target gene database data is available via <ext-link ext-link-type="uri" xlink:href="http://signal.salk.edu/creb/index.html">http://signal.salk.edu/creb/index.html</ext-link>.&#x000a0;<xref ref-type="sec" rid="Sec35">Source data</xref> are provided with this paper.</p></notes><notes notes-type="data-availability"><title>Code availability</title><p>Example code and pseudocode used for next generation sequencing data processing is provided in the Supplementary Materials section.</p></notes><notes id="FPar2" notes-type="COI-statement"><title>Competing interests</title><p id="Par73">C.H. is a scientific founder and equity holder of Aferna Green, Ellis Bio, AccuraDX, and Accent Therapeutics, and a scientific advisory board member of Aferna Green, Element Biosciences, and Rona Therapeutics. T.W. is an equity holder of AccuraDX. The remaining authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Ge</surname><given-names>EJ</given-names></name><etal/></person-group><article-title>Connecting copper and cancer: from transition metal signalling to metalloplasia</article-title><source>Nat. Rev. Cancer</source><year>2022</year><volume>22</volume><fpage>102</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1038/s41568-021-00417-2</pub-id><pub-id pub-id-type="pmid">34764459</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Ge, E. J. et al. Connecting copper and cancer: from transition metal signalling to metalloplasia. <italic>Nat. Rev. Cancer</italic><bold>22</bold>, 102&#x02013;113 (2022).<pub-id pub-id-type="pmid">34764459</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Tsvetkov</surname><given-names>P</given-names></name><etal/></person-group><article-title>Copper induces cell death by targeting lipoylated TCA cycle proteins</article-title><source>Science</source><year>2022</year><volume>375</volume><fpage>1254</fpage><lpage>1261</lpage><pub-id pub-id-type="doi">10.1126/science.abf0529</pub-id><pub-id pub-id-type="pmid">35298263</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Tsvetkov, P. et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. <italic>Science</italic><bold>375</bold>, 1254&#x02013;1261 (2022).<pub-id pub-id-type="pmid">35298263</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Ackerman</surname><given-names>CM</given-names></name><name><surname>Chang</surname><given-names>CJ</given-names></name></person-group><article-title>Copper signaling in the brain and beyond</article-title><source>J. Biol. Chem.</source><year>2018</year><volume>293</volume><fpage>4628</fpage><lpage>4635</lpage><pub-id pub-id-type="doi">10.1074/jbc.R117.000176</pub-id><pub-id pub-id-type="pmid">29084848</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Ackerman, C. M. &#x00026; Chang, C. J. Copper signaling in the brain and beyond. <italic>J. Biol. Chem.</italic><bold>293</bold>, 4628&#x02013;4635 (2018).<pub-id pub-id-type="pmid">29084848</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>CJ</given-names></name></person-group><article-title>Searching for harmony in transition-metal signaling</article-title><source>Nat. Chem. Biol.</source><year>2015</year><volume>11</volume><fpage>744</fpage><lpage>747</lpage><pub-id pub-id-type="doi">10.1038/nchembio.1913</pub-id><pub-id pub-id-type="pmid">26379012</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Chang, C. J. Searching for harmony in transition-metal signaling. <italic>Nat. Chem. Biol.</italic><bold>11</bold>, 744&#x02013;747 (2015).<pub-id pub-id-type="pmid">26379012</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Dodani</surname><given-names>SC</given-names></name><etal/></person-group><article-title>Copper is an endogenous modulator of neural circuit spontaneous activity</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2014</year><volume>111</volume><fpage>16280</fpage><lpage>16285</lpage><pub-id pub-id-type="doi">10.1073/pnas.1409796111</pub-id><pub-id pub-id-type="pmid">25378701</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Dodani, S. C. et al. Copper is an endogenous modulator of neural circuit spontaneous activity. <italic>Proc. Natl Acad. Sci. USA</italic><bold>111</bold>, 16280&#x02013;16285 (2014).<pub-id pub-id-type="pmid">25378701</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Ogra</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Changes in intracellular copper concentration and copper-regulating gene expression after PC12 differentiation into neurons</article-title><source>Sci. Rep.</source><year>2016</year><volume>6</volume><fpage>33007</fpage><pub-id pub-id-type="doi">10.1038/srep33007</pub-id><pub-id pub-id-type="pmid">27623342</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Ogra, Y. et al. Changes in intracellular copper concentration and copper-regulating gene expression after PC12 differentiation into neurons. <italic>Sci. Rep.</italic><bold>6</bold>, 33007 (2016).<pub-id pub-id-type="pmid">27623342</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>M&#x000fc;ller</surname><given-names>S</given-names></name><etal/></person-group><article-title>Metformin reveals a mitochondrial copper addiction of mesenchymal cancer cells</article-title><source>PLOS One</source><year>2018</year><volume>13</volume><fpage>e0206764</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0206764</pub-id><pub-id pub-id-type="pmid">30399175</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">M&#x000fc;ller, S. et al. Metformin reveals a mitochondrial copper addiction of mesenchymal cancer cells. <italic>PLOS One</italic><bold>13</bold>, e0206764 (2018).<pub-id pub-id-type="pmid">30399175</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnamoorthy</surname><given-names>L</given-names></name><etal/></person-group><article-title>Copper regulates cyclic-AMP-dependent lipolysis</article-title><source>Nat. Chem. Biol.</source><year>2016</year><volume>12</volume><fpage>586</fpage><lpage>592</lpage><pub-id pub-id-type="doi">10.1038/nchembio.2098</pub-id><pub-id pub-id-type="pmid">27272565</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Krishnamoorthy, L. et al. Copper regulates cyclic-AMP-dependent lipolysis. <italic>Nat. Chem. Biol.</italic><bold>12</bold>, 586&#x02013;592 (2016).<pub-id pub-id-type="pmid">27272565</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="other">Deng, H. et al. The dysregulation of inflammatory pathways triggered by copper exposure. <italic>Biol. Trace Elem. Res</italic>. <bold>201</bold>, 1&#x02013;10 (2023).</mixed-citation></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Denoyer</surname><given-names>D</given-names></name><name><surname>Masaldan</surname><given-names>S</given-names></name><name><surname>La Fontaine</surname><given-names>S</given-names></name><name><surname>Cater</surname><given-names>MA</given-names></name></person-group><article-title>Targeting copper in cancer therapy: &#x02018;copper that cancer&#x02019;</article-title><source>Metallomics</source><year>2015</year><volume>7</volume><fpage>1459</fpage><lpage>1476</lpage><pub-id pub-id-type="doi">10.1039/C5MT00149H</pub-id><pub-id pub-id-type="pmid">26313539</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Denoyer, D., Masaldan, S., La Fontaine, S. &#x00026; Cater, M. A. Targeting copper in cancer therapy: &#x02018;copper that cancer&#x02019;. <italic>Metallomics</italic><bold>7</bold>, 1459&#x02013;1476 (2015).<pub-id pub-id-type="pmid">26313539</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Gupte</surname><given-names>A</given-names></name><name><surname>Mumper</surname><given-names>RJ</given-names></name></person-group><article-title>Elevated copper and oxidative stress in cancer cells as a target for cancer treatment</article-title><source>Cancer Treat. Rev.</source><year>2009</year><volume>35</volume><fpage>32</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1016/j.ctrv.2008.07.004</pub-id><pub-id pub-id-type="pmid">18774652</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Gupte, A. &#x00026; Mumper, R. J. Elevated copper and oxidative stress in cancer cells as a target for cancer treatment. <italic>Cancer Treat. Rev.</italic><bold>35</bold>, 32&#x02013;46 (2009).<pub-id pub-id-type="pmid">18774652</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><etal/></person-group><article-title>Inhibition of human copper trafficking by a small molecule significantly attenuates cancer cell proliferation</article-title><source>Nat. Chem.</source><year>2015</year><volume>7</volume><fpage>968</fpage><lpage>979</lpage><pub-id pub-id-type="doi">10.1038/nchem.2381</pub-id><pub-id pub-id-type="pmid">26587712</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Wang, J. et al. Inhibition of human copper trafficking by a small molecule significantly attenuates cancer cell proliferation. <italic>Nat. Chem.</italic><bold>7</bold>, 968&#x02013;979 (2015).<pub-id pub-id-type="pmid">26587712</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Solier</surname><given-names>S</given-names></name><etal/></person-group><article-title>A druggable copper-signalling pathway that drives inflammation</article-title><source>Nature</source><year>2023</year><volume>617</volume><fpage>386</fpage><lpage>394</lpage><pub-id pub-id-type="doi">10.1038/s41586-023-06017-4</pub-id><pub-id pub-id-type="pmid">37100912</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Solier, S. et al. A druggable copper-signalling pathway that drives inflammation. <italic>Nature</italic><bold>617</bold>, 386&#x02013;394 (2023).<pub-id pub-id-type="pmid">37100912</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Pham</surname><given-names>VN</given-names></name><name><surname>Chang</surname><given-names>CJ</given-names></name></person-group><article-title>Metalloallostery and transition metal signaling: bioinorganic copper chemistry beyond active sites</article-title><source>Angew. Chem. Int. Ed.</source><year>2023</year><volume>62</volume><fpage>e202213644</fpage><pub-id pub-id-type="doi">10.1002/anie.202213644</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Pham, V. N. &#x00026; Chang, C. J. Metalloallostery and transition metal signaling: bioinorganic copper chemistry beyond active sites. <italic>Angew. Chem. Int. Ed.</italic><bold>62</bold>, e202213644 (2023).</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Shanbhag</surname><given-names>VC</given-names></name><etal/></person-group><article-title>Copper metabolism as a unique vulnerability in cancer</article-title><source>Biochim. Biophys. Acta Mol. Cell Res.</source><year>2020</year><volume>1868</volume><fpage>118893</fpage><pub-id pub-id-type="doi">10.1016/j.bbamcr.2020.118893</pub-id><pub-id pub-id-type="pmid">33091507</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Shanbhag, V. C. et al. Copper metabolism as a unique vulnerability in cancer. <italic>Biochim. Biophys. Acta Mol. Cell Res.</italic><bold>1868</bold>, 118893 (2020).<pub-id pub-id-type="pmid">33091507</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Prohaska</surname><given-names>JR</given-names></name><name><surname>Dagenais</surname><given-names>SL</given-names></name><name><surname>Glover</surname><given-names>TW</given-names></name><name><surname>Thiele</surname><given-names>DJ</given-names></name></person-group><article-title>Isolation of a murine copper transporter gene, tissue specific expression and functional complementation of a yeast copper transport mutant</article-title><source>Gene</source><year>2000</year><volume>254</volume><fpage>87</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1016/S0378-1119(00)00287-0</pub-id><pub-id pub-id-type="pmid">10974539</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Lee, J., Prohaska, J. R., Dagenais, S. L., Glover, T. W. &#x00026; Thiele, D. J. Isolation of a murine copper transporter gene, tissue specific expression and functional complementation of a yeast copper transport mutant. <italic>Gene</italic><bold>254</bold>, 87&#x02013;96 (2000).<pub-id pub-id-type="pmid">10974539</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>IS</given-names></name><etal/></person-group><article-title>Transcription factor Sp1 plays an important role in the regulation of copper homeostasis in mammalian cells</article-title><source>Mol. Pharmacol.</source><year>2008</year><volume>74</volume><fpage>705</fpage><lpage>713</lpage><pub-id pub-id-type="doi">10.1124/mol.108.046771</pub-id><pub-id pub-id-type="pmid">18483225</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Song, I. S. et al. Transcription factor Sp1 plays an important role in the regulation of copper homeostasis in mammalian cells. <italic>Mol. Pharmacol.</italic><bold>74</bold>, 705&#x02013;713 (2008).<pub-id pub-id-type="pmid">18483225</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>T</given-names></name><name><surname>Lyu</surname><given-names>R</given-names></name><name><surname>You</surname><given-names>Q</given-names></name><name><surname>He</surname><given-names>C</given-names></name></person-group><article-title>Kethoxal-assisted single-stranded DNA sequencing captures global transcription dynamics and enhancer activity in situ</article-title><source>Nat. Methods</source><year>2020</year><volume>17</volume><fpage>515</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.1038/s41592-020-0797-9</pub-id><pub-id pub-id-type="pmid">32251394</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Wu, T., Lyu, R., You, Q. &#x00026; He, C. Kethoxal-assisted single-stranded DNA sequencing captures global transcription dynamics and enhancer activity in situ. <italic>Nat. Methods</italic><bold>17</bold>, 515&#x02013;523 (2020).<pub-id pub-id-type="pmid">32251394</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Petris</surname><given-names>MJ</given-names></name><name><surname>Smith</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Thiele</surname><given-names>DJ</given-names></name></person-group><article-title>Copper-stimulated endocytosis and degradation of the human copper transporter, hCtr1</article-title><source>J. Biol. Chem.</source><year>2003</year><volume>278</volume><fpage>9639</fpage><lpage>9646</lpage><pub-id pub-id-type="doi">10.1074/jbc.M209455200</pub-id><pub-id pub-id-type="pmid">12501239</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Petris, M. J., Smith, K., Lee, J. &#x00026; Thiele, D. J. Copper-stimulated endocytosis and degradation of the human copper transporter, hCtr1. <italic>J. Biol. Chem.</italic><bold>278</bold>, 9639&#x02013;9646 (2003).<pub-id pub-id-type="pmid">12501239</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Birkaya</surname><given-names>B</given-names></name><name><surname>Aletta</surname><given-names>JM</given-names></name></person-group><article-title>NGF promotes copper accumulation required for optimum neurite outgrowth and protein methylation</article-title><source>J. Neurobiol.</source><year>2005</year><volume>63</volume><fpage>49</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1002/neu.20114</pub-id><pub-id pub-id-type="pmid">15627265</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Birkaya, B. &#x00026; Aletta, J. M. NGF promotes copper accumulation required for optimum neurite outgrowth and protein methylation. <italic>J. Neurobiol.</italic><bold>63</bold>, 49&#x02013;61 (2005).<pub-id pub-id-type="pmid">15627265</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Sierra-Fonseca</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Nerve growth factor induces neurite outgrowth of PC12 cells by promoting G&#x003b2;&#x003b3;-microtubule interaction</article-title><source>BMC Neurosci.</source><year>2014</year><volume>15</volume><fpage>132</fpage><pub-id pub-id-type="doi">10.1186/s12868-014-0132-4</pub-id><pub-id pub-id-type="pmid">25552352</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Sierra-Fonseca, J. A. et al. Nerve growth factor induces neurite outgrowth of PC12 cells by promoting G&#x003b2;&#x003b3;-microtubule interaction. <italic>BMC Neurosci.</italic><bold>15</bold>, 132 (2014).<pub-id pub-id-type="pmid">25552352</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>P</given-names></name><etal/></person-group><article-title>Sustained activation of M-Ras induced by nerve growth factor is essential for neuronal differentiation of PC12 cells</article-title><source>Genes Cells</source><year>2006</year><volume>11</volume><fpage>1097</fpage><lpage>1113</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2443.2006.01002.x</pub-id><pub-id pub-id-type="pmid">16923128</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Sun, P. et al. Sustained activation of M-Ras induced by nerve growth factor is essential for neuronal differentiation of PC12 cells. <italic>Genes Cells</italic><bold>11</bold>, 1097&#x02013;1113 (2006).<pub-id pub-id-type="pmid">16923128</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Ravni</surname><given-names>A</given-names></name><etal/></person-group><article-title>A cAMP-dependent, protein kinase A-independent signaling pathway mediating neuritogenesis through Egr1 in PC12 cells</article-title><source>Mol. Pharmacol.</source><year>2008</year><volume>73</volume><fpage>1688</fpage><lpage>1708</lpage><pub-id pub-id-type="doi">10.1124/mol.107.044792</pub-id><pub-id pub-id-type="pmid">18362103</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Ravni, A. et al. A cAMP-dependent, protein kinase A-independent signaling pathway mediating neuritogenesis through Egr1 in PC12 cells. <italic>Mol. Pharmacol.</italic><bold>73</bold>, 1688&#x02013;1708 (2008).<pub-id pub-id-type="pmid">18362103</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Kirsipuu</surname><given-names>T</given-names></name><etal/></person-group><article-title>Copper(ii)-binding equilibria in human blood</article-title><source>Sci. Rep.</source><year>2020</year><volume>10</volume><fpage>5686</fpage><pub-id pub-id-type="doi">10.1038/s41598-020-62560-4</pub-id><pub-id pub-id-type="pmid">32231266</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Kirsipuu, T. et al. Copper(ii)-binding equilibria in human blood. <italic>Sci. Rep.</italic><bold>10</bold>, 5686 (2020).<pub-id pub-id-type="pmid">32231266</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Olusi</surname><given-names>S</given-names></name><name><surname>Al-Awadhi</surname><given-names>A</given-names></name><name><surname>Abiaka</surname><given-names>C</given-names></name><name><surname>Abraham</surname><given-names>M</given-names></name><name><surname>George</surname><given-names>S</given-names></name></person-group><article-title>Serum copper levels and not zinc are positively associated with serum leptin concentrations in the healthy adult population</article-title><source>Biol. Trace Elem. Res.</source><year>2003</year><volume>91</volume><fpage>137</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1385/BTER:91:2:137</pub-id><pub-id pub-id-type="pmid">12719608</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Olusi, S., Al-Awadhi, A., Abiaka, C., Abraham, M. &#x00026; George, S. Serum copper levels and not zinc are positively associated with serum leptin concentrations in the healthy adult population. <italic>Biol. Trace Elem. Res.</italic><bold>91</bold>, 137&#x02013;144 (2003).<pub-id pub-id-type="pmid">12719608</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Fallahi</surname><given-names>M</given-names></name><name><surname>Amelio</surname><given-names>AL</given-names></name><name><surname>Cleveland</surname><given-names>JL</given-names></name><name><surname>Rounbehler</surname><given-names>RJ</given-names></name></person-group><article-title>CREB targets define the gene expression signature of malignancies having reduced levels of the tumor suppressor tristetraprolin</article-title><source>PLOS ONE</source><year>2014</year><volume>9</volume><fpage>e115517</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0115517</pub-id><pub-id pub-id-type="pmid">25541715</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Fallahi, M., Amelio, A. L., Cleveland, J. L. &#x00026; Rounbehler, R. J. CREB targets define the gene expression signature of malignancies having reduced levels of the tumor suppressor tristetraprolin. <italic>PLOS ONE</italic><bold>9</bold>, e115517 (2014).<pub-id pub-id-type="pmid">25541715</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Yue</surname><given-names>J</given-names></name><etal/></person-group><article-title>Integrator orchestrates RAS/ERK1/2 signaling transcriptional programs</article-title><source>Genes Dev.</source><year>2017</year><volume>31</volume><fpage>1809</fpage><lpage>1820</lpage><pub-id pub-id-type="doi">10.1101/gad.301697.117</pub-id><pub-id pub-id-type="pmid">28982763</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Yue, J. et al. Integrator orchestrates RAS/ERK1/2 signaling transcriptional programs. <italic>Genes Dev.</italic><bold>31</bold>, 1809&#x02013;1820 (2017).<pub-id pub-id-type="pmid">28982763</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Price</surname><given-names>KA</given-names></name><etal/></person-group><article-title>Sustained activation of glial cell epidermal growth factor receptor by bis (thiosemicarbazonato) metal complexes is associated with inhibition of protein tyrosine phosphatase activity</article-title><source>J. Med. Chem.</source><year>2009</year><volume>52</volume><fpage>6606</fpage><lpage>6620</lpage><pub-id pub-id-type="doi">10.1021/jm9007938</pub-id><pub-id pub-id-type="pmid">19807095</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Price, K. A. et al. Sustained activation of glial cell epidermal growth factor receptor by bis (thiosemicarbazonato) metal complexes is associated with inhibition of protein tyrosine phosphatase activity. <italic>J. Med. Chem.</italic><bold>52</bold>, 6606&#x02013;6620 (2009).<pub-id pub-id-type="pmid">19807095</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Yamaoka</surname><given-names>T</given-names></name><name><surname>Frey</surname><given-names>MR</given-names></name><name><surname>Dise</surname><given-names>RS</given-names></name><name><surname>Bernard</surname><given-names>JK</given-names></name><name><surname>Polk</surname><given-names>DB</given-names></name></person-group><article-title>Specific epidermal growth factor receptor autophosphorylation sites promote mouse colon epithelial cell chemotaxis and restitution</article-title><source>Am. J. Physiol. Gastrointest. Liver. Physiol.</source><year>2011</year><volume>301</volume><fpage>G368</fpage><lpage>G376</lpage><pub-id pub-id-type="doi">10.1152/ajpgi.00327.2010</pub-id><pub-id pub-id-type="pmid">21617115</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Yamaoka, T., Frey, M. R., Dise, R. S., Bernard, J. K. &#x00026; Polk, D. B. Specific epidermal growth factor receptor autophosphorylation sites promote mouse colon epithelial cell chemotaxis and restitution. <italic>Am. J. Physiol. Gastrointest. Liver. Physiol.</italic><bold>301</bold>, G368&#x02013;G376 (2011).<pub-id pub-id-type="pmid">21617115</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Lazarovici</surname><given-names>P</given-names></name><name><surname>Quirion</surname><given-names>R</given-names></name><name><surname>Zheng</surname><given-names>W</given-names></name></person-group><article-title>cAMP response element-binding protein (CREB): a possible signaling molecule link in the pathophysiology of schizophrenia</article-title><source>Front. Mol. Neurosci.</source><year>2018</year><volume>11</volume><fpage>255</fpage><pub-id pub-id-type="doi">10.3389/fnmol.2018.00255</pub-id><pub-id pub-id-type="pmid">30214393</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Wang, H., Xu, J., Lazarovici, P., Quirion, R. &#x00026; Zheng, W. cAMP response element-binding protein (CREB): a possible signaling molecule link in the pathophysiology of schizophrenia. <italic>Front. Mol. Neurosci.</italic><bold>11</bold>, 255 (2018).<pub-id pub-id-type="pmid">30214393</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Lawson</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Pulse sensitivity of the luteinizing hormone &#x003b2; promoter is determined by a negative feedback loop involving early growth response-1 and Ngfi-A binding protein 1 and 2</article-title><source>Mol. Endocrinol.</source><year>2007</year><volume>21</volume><fpage>1175</fpage><lpage>1191</lpage><pub-id pub-id-type="doi">10.1210/me.2006-0392</pub-id><pub-id pub-id-type="pmid">17299135</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Lawson, M. A. et al. Pulse sensitivity of the luteinizing hormone &#x003b2; promoter is determined by a negative feedback loop involving early growth response-1 and Ngfi-A binding protein 1 and 2. <italic>Mol. Endocrinol.</italic><bold>21</bold>, 1175&#x02013;1191 (2007).<pub-id pub-id-type="pmid">17299135</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Lucerna</surname><given-names>M</given-names></name><etal/></person-group><article-title>NAB2, a corepressor of EGR-1, inhibits vascular endothelial growth factor-mediated gene induction and angiogenic responses of endothelial cells</article-title><source>J. Biol. Chem.</source><year>2003</year><volume>278</volume><fpage>11433</fpage><lpage>11440</lpage><pub-id pub-id-type="doi">10.1074/jbc.M204937200</pub-id><pub-id pub-id-type="pmid">12427750</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Lucerna, M. et al. NAB2, a corepressor of EGR-1, inhibits vascular endothelial growth factor-mediated gene induction and angiogenic responses of endothelial cells. <italic>J. Biol. Chem.</italic><bold>278</bold>, 11433&#x02013;11440 (2003).<pub-id pub-id-type="pmid">12427750</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Oki</surname><given-names>S</given-names></name><etal/></person-group><article-title>ChIP&#x02010;Atlas: a data&#x02010;mining suite powered by full integration of public ChIP&#x02010;seq data</article-title><source>EMBO Rep.</source><year>2018</year><volume>19</volume><fpage>e46255</fpage><pub-id pub-id-type="doi">10.15252/embr.201846255</pub-id><pub-id pub-id-type="pmid">30413482</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Oki, S. et al. ChIP&#x02010;Atlas: a data&#x02010;mining suite powered by full integration of public ChIP&#x02010;seq data. <italic>EMBO Rep.</italic><bold>19</bold>, e46255 (2018).<pub-id pub-id-type="pmid">30413482</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="other">Zou, Z., Ohta, T., Miura, F. &#x00026; Oki, S. ChIP-Atlas 2021 update: a data-mining suite for exploring epigenomic landscapes by fully integrating ChIP-seq, ATAC-seq and Bisulfite-seq data. <italic>Nucleic Acids Res</italic>. <bold>50</bold>, W175&#x02013;W182 (2022).</mixed-citation></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><etal/></person-group><article-title>Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2005</year><volume>102</volume><fpage>4459</fpage><lpage>4464</lpage><pub-id pub-id-type="doi">10.1073/pnas.0501076102</pub-id><pub-id pub-id-type="pmid">15753290</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Zhang, X. et al. Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. <italic>Proc. Natl. Acad. Sci. USA</italic><bold>102</bold>, 4459&#x02013;4464 (2005).<pub-id pub-id-type="pmid">15753290</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Parra-Damas</surname><given-names>A</given-names></name><name><surname>Rubi&#x000f3;-Ferrarons</surname><given-names>L</given-names></name><name><surname>Shen</surname><given-names>J</given-names></name><name><surname>Saura</surname><given-names>CA</given-names></name></person-group><article-title>CRTC1 mediates preferential transcription at neuronal activity-regulated CRE/TATA promoters</article-title><source>Sci. Rep.</source><year>2017</year><volume>7</volume><fpage>18004</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-18215-y</pub-id><pub-id pub-id-type="pmid">29269871</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Parra-Damas, A., Rubi&#x000f3;-Ferrarons, L., Shen, J. &#x00026; Saura, C. A. CRTC1 mediates preferential transcription at neuronal activity-regulated CRE/TATA promoters. <italic>Sci. Rep.</italic><bold>7</bold>, 18004 (2017).<pub-id pub-id-type="pmid">29269871</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Pellegrini</surname><given-names>M</given-names></name><etal/></person-group><article-title>Expression profile of CREB knockdown in myeloid leukemia cells</article-title><source>BMC Cancer</source><year>2008</year><volume>8</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1186/1471-2407-8-264</pub-id><pub-id pub-id-type="pmid">18173856</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Pellegrini, M. et al. Expression profile of CREB knockdown in myeloid leukemia cells. <italic>BMC Cancer</italic><bold>8</bold>, 1&#x02013;12 (2008).<pub-id pub-id-type="pmid">18173856</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Ni</surname><given-names>P</given-names></name><etal/></person-group><article-title>Targeting fibroblast growth factor 23-responsive pathways uncovers controlling genes in kidney mineral metabolism</article-title><source>Kidney Int.</source><year>2021</year><volume>99</volume><fpage>598</fpage><lpage>608</lpage><pub-id pub-id-type="doi">10.1016/j.kint.2020.10.024</pub-id><pub-id pub-id-type="pmid">33159963</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Ni, P. et al. Targeting fibroblast growth factor 23-responsive pathways uncovers controlling genes in kidney mineral metabolism. <italic>Kidney Int.</italic><bold>99</bold>, 598&#x02013;608 (2021).<pub-id pub-id-type="pmid">33159963</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharyya</surname><given-names>S</given-names></name><etal/></person-group><article-title>The transcriptional cofactor Nab2 is induced by TGF-&#x003b2; and suppresses fibroblast activation: physiological roles and impaired expression in scleroderma</article-title><source>PLOS One</source><year>2009</year><volume>4</volume><fpage>e7620</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0007620</pub-id><pub-id pub-id-type="pmid">19888474</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Bhattacharyya, S. et al. The transcriptional cofactor Nab2 is induced by TGF-&#x003b2; and suppresses fibroblast activation: physiological roles and impaired expression in scleroderma. <italic>PLOS One</italic><bold>4</bold>, e7620 (2009).<pub-id pub-id-type="pmid">19888474</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>H</given-names></name><etal/></person-group><article-title>NR4A1 regulates expression of immediate early genes, suppressing replication stress in cancer</article-title><source>Mol. Cell</source><year>2021</year><volume>81</volume><fpage>4041</fpage><lpage>4058.e15</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2021.09.016</pub-id><pub-id pub-id-type="pmid">34624217</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Guo, H. et al. NR4A1 regulates expression of immediate early genes, suppressing replication stress in cancer. <italic>Mol. Cell</italic><bold>81</bold>, 4041&#x02013;4058.e15 (2021).<pub-id pub-id-type="pmid">34624217</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y</given-names></name><etal/></person-group><article-title>TGF-&#x003b2; transactivates EGFR and facilitates breast cancer migration and invasion through canonical Smad3 and ERK/Sp1 signaling pathways</article-title><source>Mol. Oncol.</source><year>2018</year><volume>12</volume><fpage>305</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1002/1878-0261.12162</pub-id><pub-id pub-id-type="pmid">29215776</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Zhao, Y. et al. TGF-&#x003b2; transactivates EGFR and facilitates breast cancer migration and invasion through canonical Smad3 and ERK/Sp1 signaling pathways. <italic>Mol. Oncol.</italic><bold>12</bold>, 305&#x02013;321 (2018).<pub-id pub-id-type="pmid">29215776</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>K</given-names></name><etal/></person-group><article-title>Stress-induced endocytosis and degradation of epidermal growth factor receptor are two independent processes</article-title><source>Cancer Cell</source><year>2016</year><volume>16</volume><fpage>25</fpage><pub-id pub-id-type="doi">10.1186/s12935-016-0301-x</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Peng, K. et al. Stress-induced endocytosis and degradation of epidermal growth factor receptor are two independent processes. <italic>Cancer Cell</italic><bold>16</bold>, 25 (2016).</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Bessman</surname><given-names>NJ</given-names></name><name><surname>Bagchi</surname><given-names>A</given-names></name><name><surname>Ferguson</surname><given-names>KM</given-names></name><name><surname>Lemmon</surname><given-names>MA</given-names></name></person-group><article-title>Complex relationship between ligand binding and dimerization in the epidermal growth factor receptor</article-title><source>Cell Rep.</source><year>2014</year><volume>9</volume><fpage>1306</fpage><lpage>1317</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2014.10.010</pub-id><pub-id pub-id-type="pmid">25453753</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Bessman, N. J., Bagchi, A., Ferguson, K. M. &#x00026; Lemmon, M. A. Complex relationship between ligand binding and dimerization in the epidermal growth factor receptor. <italic>Cell Rep.</italic><bold>9</bold>, 1306&#x02013;1317 (2014).<pub-id pub-id-type="pmid">25453753</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>F</given-names></name><etal/></person-group><article-title>Copper (ii) ions activate ligand-independent receptor tyrosine kinase (RTK) signaling pathway</article-title><source>Biomed. Res. Int.</source><year>2019</year><volume>2019</volume><fpage>4158415</fpage><pub-id pub-id-type="doi">10.1155/2019/4158415</pub-id><pub-id pub-id-type="pmid">31218225</pub-id>
</element-citation><mixed-citation id="mc-CR44" publication-type="journal">He, F. et al. Copper (ii) ions activate ligand-independent receptor tyrosine kinase (RTK) signaling pathway. <italic>Biomed. Res. Int.</italic><bold>2019</bold>, 4158415 (2019).<pub-id pub-id-type="pmid">31218225</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Vidovi&#x00107;</surname><given-names>D</given-names></name><name><surname>Sch&#x000fc;rer</surname><given-names>SC</given-names></name></person-group><article-title>Knowledge-based characterization of similarity relationships in the human protein-tyrosine phosphatase family for rational inhibitor design</article-title><source>J. Med. Chem.</source><year>2009</year><volume>52</volume><fpage>6649</fpage><lpage>6659</lpage><pub-id pub-id-type="doi">10.1021/jm9008899</pub-id><pub-id pub-id-type="pmid">19810703</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Vidovi&#x00107;, D. &#x00026; Sch&#x000fc;rer, S. C. Knowledge-based characterization of similarity relationships in the human protein-tyrosine phosphatase family for rational inhibitor design. <italic>J. Med. Chem.</italic><bold>52</bold>, 6649&#x02013;6659 (2009).<pub-id pub-id-type="pmid">19810703</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Paul</surname><given-names>G</given-names></name><name><surname>Marchelletta</surname><given-names>RR</given-names></name><name><surname>McCole</surname><given-names>DF</given-names></name><name><surname>Barrett</surname><given-names>KE</given-names></name></person-group><article-title>Interferon-&#x003b3; alters downstream signaling originating from epidermal growth factor receptor in intestinal epithelial cells: functional consequences for ion transport</article-title><source>J. Biol. Chem.</source><year>2012</year><volume>287</volume><fpage>2144</fpage><lpage>2155</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.318139</pub-id><pub-id pub-id-type="pmid">22069319</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Paul, G., Marchelletta, R. R., McCole, D. F. &#x00026; Barrett, K. E. Interferon-&#x003b3; alters downstream signaling originating from epidermal growth factor receptor in intestinal epithelial cells: functional consequences for ion transport. <italic>J. Biol. Chem.</italic><bold>287</bold>, 2144&#x02013;2155 (2012).<pub-id pub-id-type="pmid">22069319</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Baumdick</surname><given-names>M</given-names></name><etal/></person-group><article-title>EGF-dependent re-routing of vesicular recycling switches spontaneous phosphorylation suppression to EGFR signaling</article-title><source>eLife</source><year>2015</year><volume>4</volume><fpage>e12223</fpage><pub-id pub-id-type="doi">10.7554/eLife.12223</pub-id><pub-id pub-id-type="pmid">26609808</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">Baumdick, M. et al. EGF-dependent re-routing of vesicular recycling switches spontaneous phosphorylation suppression to EGFR signaling. <italic>eLife</italic><bold>4</bold>, e12223 (2015).<pub-id pub-id-type="pmid">26609808</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name><surname>Stanoev</surname><given-names>A</given-names></name><etal/></person-group><article-title>Interdependence between EGFR and phosphatases spatially established by vesicular dynamics generates a growth factor sensing and responding network</article-title><source>Cell Syst.</source><year>2018</year><volume>7</volume><fpage>295</fpage><lpage>309. e11</lpage><pub-id pub-id-type="doi">10.1016/j.cels.2018.06.006</pub-id><pub-id pub-id-type="pmid">30145116</pub-id>
</element-citation><mixed-citation id="mc-CR48" publication-type="journal">Stanoev, A. et al. Interdependence between EGFR and phosphatases spatially established by vesicular dynamics generates a growth factor sensing and responding network. <italic>Cell Syst.</italic><bold>7</bold>, 295&#x02013;309. e11 (2018).<pub-id pub-id-type="pmid">30145116</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Scharl</surname><given-names>M</given-names></name><name><surname>Rudenko</surname><given-names>I</given-names></name><name><surname>McCole</surname><given-names>DF</given-names></name></person-group><article-title>Loss of protein tyrosine phosphatase N2 potentiates epidermal growth factor suppression of intestinal epithelial chloride secretion</article-title><source>Am. J. Physiol. Gastrointest. Liver Physiol.</source><year>2010</year><volume>299</volume><fpage>G935</fpage><lpage>G945</lpage><pub-id pub-id-type="doi">10.1152/ajpgi.00106.2010</pub-id><pub-id pub-id-type="pmid">20689057</pub-id>
</element-citation><mixed-citation id="mc-CR49" publication-type="journal">Scharl, M., Rudenko, I. &#x00026; McCole, D. F. Loss of protein tyrosine phosphatase N2 potentiates epidermal growth factor suppression of intestinal epithelial chloride secretion. <italic>Am. J. Physiol. Gastrointest. Liver Physiol.</italic><bold>299</bold>, G935&#x02013;G945 (2010).<pub-id pub-id-type="pmid">20689057</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name><surname>Bleidorn</surname><given-names>J</given-names></name><etal/></person-group><article-title>The pro-inflammatory stimulus of zinc- and copper-containing welding fumes in whole blood assay via protein tyrosine phosphatase 1B inhibition</article-title><source>Sci. Rep.</source><year>2019</year><volume>9</volume><fpage>1315</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-37803-0</pub-id><pub-id pub-id-type="pmid">30718726</pub-id>
</element-citation><mixed-citation id="mc-CR50" publication-type="journal">Bleidorn, J. et al. The pro-inflammatory stimulus of zinc- and copper-containing welding fumes in whole blood assay via protein tyrosine phosphatase 1B inhibition. <italic>Sci. Rep.</italic><bold>9</bold>, 1315 (2019).<pub-id pub-id-type="pmid">30718726</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name><surname>Krabbe</surname><given-names>J</given-names></name><etal/></person-group><article-title>The effects of zinc-and copper-containing welding fumes on murine, rat and human precision-cut lung slices</article-title><source>J. Trace Elem. Med. Bio.</source><year>2018</year><volume>49</volume><fpage>192</fpage><lpage>201</lpage><pub-id pub-id-type="doi">10.1016/j.jtemb.2018.03.008</pub-id><pub-id pub-id-type="pmid">29551464</pub-id>
</element-citation><mixed-citation id="mc-CR51" publication-type="journal">Krabbe, J. et al. The effects of zinc-and copper-containing welding fumes on murine, rat and human precision-cut lung slices. <italic>J. Trace Elem. Med. Bio.</italic><bold>49</bold>, 192&#x02013;201 (2018).<pub-id pub-id-type="pmid">29551464</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>W</given-names></name><etal/></person-group><article-title>Activation of the EGF receptor signaling pathway in human airway epithelial cells exposed to metals</article-title><source>Am. J. Physiol. Lung Cell. Mol. Physiol.</source><year>1999</year><volume>277</volume><fpage>L924</fpage><lpage>L931</lpage><pub-id pub-id-type="doi">10.1152/ajplung.1999.277.5.L924</pub-id></element-citation><mixed-citation id="mc-CR52" publication-type="journal">Wu, W. et al. Activation of the EGF receptor signaling pathway in human airway epithelial cells exposed to metals. <italic>Am. J. Physiol. Lung Cell. Mol. Physiol.</italic><bold>277</bold>, L924&#x02013;L931 (1999).</mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>KB</given-names></name><name><surname>Maret</surname><given-names>W</given-names></name></person-group><article-title>The interactions of metal cations and oxyanions with protein tyrosine phosphatase 1B</article-title><source>BioMetals</source><year>2017</year><volume>30</volume><fpage>517</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1007/s10534-017-0019-9</pub-id><pub-id pub-id-type="pmid">28540523</pub-id>
</element-citation><mixed-citation id="mc-CR53" publication-type="journal">Singh, K. B. &#x00026; Maret, W. The interactions of metal cations and oxyanions with protein tyrosine phosphatase 1B. <italic>BioMetals</italic><bold>30</bold>, 517&#x02013;527 (2017).<pub-id pub-id-type="pmid">28540523</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name><surname>Poursani</surname><given-names>EM</given-names></name><etal/></person-group><article-title>Copper chelation suppresses epithelial-mesenchymal transition by inhibition of canonical and non-canonical TGF-&#x003b2; signaling pathways in cancer</article-title><source>Cell Biosci.</source><year>2023</year><volume>13</volume><fpage>132</fpage><pub-id pub-id-type="doi">10.1186/s13578-023-01083-7</pub-id><pub-id pub-id-type="pmid">37480151</pub-id>
</element-citation><mixed-citation id="mc-CR54" publication-type="journal">Poursani, E. M. et al. Copper chelation suppresses epithelial-mesenchymal transition by inhibition of canonical and non-canonical TGF-&#x003b2; signaling pathways in cancer. <italic>Cell Biosci.</italic><bold>13</bold>, 132 (2023).<pub-id pub-id-type="pmid">37480151</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>P</given-names></name><etal/></person-group><article-title>Gene expression profiling of liver cells after copper overload in vivo and in vitro reveals new copper-regulated genes</article-title><source>J. Biol. Inorg. Chem.</source><year>2007</year><volume>12</volume><fpage>495</fpage><lpage>507</lpage><pub-id pub-id-type="doi">10.1007/s00775-006-0201-y</pub-id><pub-id pub-id-type="pmid">17211630</pub-id>
</element-citation><mixed-citation id="mc-CR55" publication-type="journal">Muller, P. et al. Gene expression profiling of liver cells after copper overload in vivo and in vitro reveals new copper-regulated genes. <italic>J. Biol. Inorg. Chem.</italic><bold>12</bold>, 495&#x02013;507 (2007).<pub-id pub-id-type="pmid">17211630</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name><surname>Voli</surname><given-names>F</given-names></name><etal/></person-group><article-title>Intratumoral copper modulates PD-L1 expression and influences tumor immune evasion</article-title><source>Cancer Res.</source><year>2020</year><volume>80</volume><fpage>4129</fpage><lpage>4144</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-20-0471</pub-id><pub-id pub-id-type="pmid">32816860</pub-id>
</element-citation><mixed-citation id="mc-CR56" publication-type="journal">Voli, F. et al. Intratumoral copper modulates PD-L1 expression and influences tumor immune evasion. <italic>Cancer Res.</italic><bold>80</bold>, 4129&#x02013;4144 (2020).<pub-id pub-id-type="pmid">32816860</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Potent inhibition of protein tyrosine phosphatase 1B by copper complexes: implications for copper toxicity in biological systems</article-title><source>Chem. Commun.</source><year>2010</year><volume>46</volume><fpage>3547</fpage><lpage>3549</lpage><pub-id pub-id-type="doi">10.1039/b925603b</pub-id></element-citation><mixed-citation id="mc-CR57" publication-type="journal">Wang, Q. et al. Potent inhibition of protein tyrosine phosphatase 1B by copper complexes: implications for copper toxicity in biological systems. <italic>Chem. Commun.</italic><bold>46</bold>, 3547&#x02013;3549 (2010).</mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name><surname>Bellomo</surname><given-names>E</given-names></name><name><surname>Birla Singh</surname><given-names>K</given-names></name><name><surname>Massarotti</surname><given-names>A</given-names></name><name><surname>Hogstrand</surname><given-names>C</given-names></name><name><surname>Maret</surname><given-names>W</given-names></name></person-group><article-title>The metal face of protein tyrosine phosphatase 1B</article-title><source>Coord. Chem. Rev.</source><year>2016</year><volume>327-328</volume><fpage>70</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/j.ccr.2016.07.002</pub-id><pub-id pub-id-type="pmid">27890939</pub-id>
</element-citation><mixed-citation id="mc-CR58" publication-type="journal">Bellomo, E., Birla Singh, K., Massarotti, A., Hogstrand, C. &#x00026; Maret, W. The metal face of protein tyrosine phosphatase 1B. <italic>Coord. Chem. Rev.</italic><bold>327-328</bold>, 70&#x02013;83 (2016).<pub-id pub-id-type="pmid">27890939</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Zhu</surname><given-names>M</given-names></name></person-group><article-title>Metal-based inhibitors of protein tyrosine phosphatases</article-title><source>Anti Cancer Agents Med. Chem.</source><year>2011</year><volume>11</volume><fpage>164</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.2174/187152011794941271</pub-id></element-citation><mixed-citation id="mc-CR59" publication-type="journal">Lu, L. &#x00026; Zhu, M. Metal-based inhibitors of protein tyrosine phosphatases. <italic>Anti Cancer Agents Med. Chem.</italic><bold>11</bold>, 164&#x02013;171 (2011).</mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name><surname>Punthasee</surname><given-names>P</given-names></name><etal/></person-group><article-title>Covalent allosteric inactivation of protein tyrosine phosphatase 1B (PTP1B) by an inhibitor&#x02013;electrophile conjugate</article-title><source>Biochemistry</source><year>2017</year><volume>56</volume><fpage>2051</fpage><lpage>2060</lpage><pub-id pub-id-type="doi">10.1021/acs.biochem.7b00151</pub-id><pub-id pub-id-type="pmid">28345882</pub-id>
</element-citation><mixed-citation id="mc-CR60" publication-type="journal">Punthasee, P. et al. Covalent allosteric inactivation of protein tyrosine phosphatase 1B (PTP1B) by an inhibitor&#x02013;electrophile conjugate. <italic>Biochemistry</italic><bold>56</bold>, 2051&#x02013;2060 (2017).<pub-id pub-id-type="pmid">28345882</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name><surname>Price</surname><given-names>KA</given-names></name><etal/></person-group><article-title>Activation of epidermal growth factor receptor by metal-ligand complexes decreases levels of extracellular amyloid beta peptide</article-title><source>Int. J. Biochem. Cell Biol.</source><year>2008</year><volume>40</volume><fpage>1901</fpage><lpage>1917</lpage><pub-id pub-id-type="doi">10.1016/j.biocel.2008.01.033</pub-id><pub-id pub-id-type="pmid">18346929</pub-id>
</element-citation><mixed-citation id="mc-CR61" publication-type="journal">Price, K. A. et al. Activation of epidermal growth factor receptor by metal-ligand complexes decreases levels of extracellular amyloid beta peptide. <italic>Int. J. Biochem. Cell Biol.</italic><bold>40</bold>, 1901&#x02013;1917 (2008).<pub-id pub-id-type="pmid">18346929</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>Z</given-names></name><etal/></person-group><article-title>A global analysis of the receptor tyrosine kinase-protein phosphatase interactome</article-title><source>Mol. Cell</source><year>2017</year><volume>65</volume><fpage>347</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2016.12.004</pub-id><pub-id pub-id-type="pmid">28065597</pub-id>
</element-citation><mixed-citation id="mc-CR62" publication-type="journal">Yao, Z. et al. A global analysis of the receptor tyrosine kinase-protein phosphatase interactome. <italic>Mol. Cell</italic><bold>65</bold>, 347&#x02013;360 (2017).<pub-id pub-id-type="pmid">28065597</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name><surname>Travaglia</surname><given-names>A</given-names></name><etal/></person-group><article-title>A small linear peptide encompassing the NGF N-terminus partly mimics the biological activities of the entire neurotrophin in PC12 cells</article-title><source>ACS Chem. Neurosci.</source><year>2015</year><volume>6</volume><fpage>1379</fpage><lpage>1392</lpage><pub-id pub-id-type="doi">10.1021/acschemneuro.5b00069</pub-id><pub-id pub-id-type="pmid">25939060</pub-id>
</element-citation><mixed-citation id="mc-CR63" publication-type="journal">Travaglia, A. et al. A small linear peptide encompassing the NGF N-terminus partly mimics the biological activities of the entire neurotrophin in PC12 cells. <italic>ACS Chem. Neurosci.</italic><bold>6</bold>, 1379&#x02013;1392 (2015).<pub-id pub-id-type="pmid">25939060</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name><surname>Pandini</surname><given-names>G</given-names></name><etal/></person-group><article-title>The inorganic side of NGF: Copper(ii) and Zinc(ii) Affect the NGF mimicking signaling of the N-terminus peptides encompassing the recognition domain of TrkA receptor</article-title><source>Front. Neurosci.</source><year>2016</year><volume>10</volume><fpage>569</fpage><pub-id pub-id-type="doi">10.3389/fnins.2016.00569</pub-id><pub-id pub-id-type="pmid">28090201</pub-id>
</element-citation><mixed-citation id="mc-CR64" publication-type="journal">Pandini, G. et al. The inorganic side of NGF: Copper(ii) and Zinc(ii) Affect the NGF mimicking signaling of the N-terminus peptides encompassing the recognition domain of TrkA receptor. <italic>Front. Neurosci.</italic><bold>10</bold>, 569 (2016).<pub-id pub-id-type="pmid">28090201</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name><surname>La Mendola</surname><given-names>D</given-names></name><name><surname>Arena</surname><given-names>G</given-names></name><name><surname>Pietropaolo</surname><given-names>A</given-names></name><name><surname>Satriano</surname><given-names>C</given-names></name><name><surname>Rizzarelli</surname><given-names>E</given-names></name></person-group><article-title>Metal ion coordination in peptide fragments of neurotrophins: a crucial step for understanding the role and signaling of these proteins in the brain</article-title><source>Coord. Chem. Rev.</source><year>2021</year><volume>435</volume><fpage>213790</fpage><pub-id pub-id-type="doi">10.1016/j.ccr.2021.213790</pub-id></element-citation><mixed-citation id="mc-CR65" publication-type="journal">La Mendola, D., Arena, G., Pietropaolo, A., Satriano, C. &#x00026; Rizzarelli, E. Metal ion coordination in peptide fragments of neurotrophins: a crucial step for understanding the role and signaling of these proteins in the brain. <italic>Coord. Chem. Rev.</italic><bold>435</bold>, 213790 (2021).</mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name><surname>Yong</surname><given-names>L</given-names></name><etal/></person-group><article-title>p53 inhibits CTR1-mediated cisplatin absorption by suppressing SP1 nuclear translocation in osteosarcoma</article-title><source>Front. Oncol.</source><year>2022</year><volume>12</volume><fpage>1047194</fpage><pub-id pub-id-type="doi">10.3389/fonc.2022.1047194</pub-id><pub-id pub-id-type="pmid">36776364</pub-id>
</element-citation><mixed-citation id="mc-CR66" publication-type="journal">Yong, L. et al. p53 inhibits CTR1-mediated cisplatin absorption by suppressing SP1 nuclear translocation in osteosarcoma. <italic>Front. Oncol.</italic><bold>12</bold>, 1047194 (2022).<pub-id pub-id-type="pmid">36776364</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name><surname>Kuo</surname><given-names>MT</given-names></name><name><surname>Huang</surname><given-names>YF</given-names></name><name><surname>Chou</surname><given-names>CY</given-names></name><name><surname>Chen</surname><given-names>HHW</given-names></name></person-group><article-title>Targeting the copper transport system to improve treatment efficacies of platinum-containing drugs in cancer chemotherapy</article-title><source>Pharm. (Basel)</source><year>2021</year><volume>14</volume><fpage>549</fpage></element-citation><mixed-citation id="mc-CR67" publication-type="journal">Kuo, M. T., Huang, Y. F., Chou, C. Y. &#x00026; Chen, H. H. W. Targeting the copper transport system to improve treatment efficacies of platinum-containing drugs in cancer chemotherapy. <italic>Pharm. (Basel)</italic><bold>14</bold>, 549 (2021).</mixed-citation></citation-alternatives></ref><ref id="CR68"><label>68.</label><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>ZD</given-names></name><name><surname>Tsai</surname><given-names>W-B</given-names></name><name><surname>Lee</surname><given-names>M-Y</given-names></name><name><surname>Savaraj</surname><given-names>N</given-names></name><name><surname>Kuo</surname><given-names>MT</given-names></name></person-group><article-title>Specificity protein 1 (Sp1) oscillation is involved in copper homeostasis maintenance by regulating human high-affinity copper transporter 1 expression</article-title><source>Mol. Pharmacol.</source><year>2012</year><volume>81</volume><fpage>455</fpage><lpage>464</lpage><pub-id pub-id-type="doi">10.1124/mol.111.076422</pub-id><pub-id pub-id-type="pmid">22172574</pub-id>
</element-citation><mixed-citation id="mc-CR68" publication-type="journal">Liang, Z. D., Tsai, W.-B., Lee, M.-Y., Savaraj, N. &#x00026; Kuo, M. T. Specificity protein 1 (Sp1) oscillation is involved in copper homeostasis maintenance by regulating human high-affinity copper transporter 1 expression. <italic>Mol. Pharmacol.</italic><bold>81</bold>, 455&#x02013;464 (2012).<pub-id pub-id-type="pmid">22172574</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR69"><label>69.</label><citation-alternatives><element-citation id="ec-CR69" publication-type="journal"><person-group person-group-type="author"><name><surname>Barca</surname><given-names>A</given-names></name><etal/></person-group><article-title>Carnosine modulates the Sp1-Slc31a1/Ctr1 copper-sensing system and influences copper homeostasis in murine CNS-derived cells</article-title><source>Am. J. Physiol. Cell Physiol.</source><year>2019</year><volume>316</volume><fpage>C235</fpage><lpage>C245</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00106.2018</pub-id><pub-id pub-id-type="pmid">30485136</pub-id>
</element-citation><mixed-citation id="mc-CR69" publication-type="journal">Barca, A. et al. Carnosine modulates the Sp1-Slc31a1/Ctr1 copper-sensing system and influences copper homeostasis in murine CNS-derived cells. <italic>Am. J. Physiol. Cell Physiol.</italic><bold>316</bold>, C235&#x02013;C245 (2019).<pub-id pub-id-type="pmid">30485136</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR70"><label>70.</label><citation-alternatives><element-citation id="ec-CR70" publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Xi</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name></person-group><article-title>Copper-finger protein of Sp1: the molecular basis of copper sensing</article-title><source>Metallomics</source><year>2017</year><volume>9</volume><fpage>1169</fpage><lpage>1175</lpage><pub-id pub-id-type="doi">10.1039/C7MT00184C</pub-id><pub-id pub-id-type="pmid">28759062</pub-id>
</element-citation><mixed-citation id="mc-CR70" publication-type="journal">Yuan, S., Chen, S., Xi, Z. &#x00026; Liu, Y. Copper-finger protein of Sp1: the molecular basis of copper sensing. <italic>Metallomics</italic><bold>9</bold>, 1169&#x02013;1175 (2017).<pub-id pub-id-type="pmid">28759062</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR71"><label>71.</label><citation-alternatives><element-citation id="ec-CR71" publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>D</given-names></name><name><surname>Aiba</surname><given-names>I</given-names></name><name><surname>Chen</surname><given-names>HHW</given-names></name><name><surname>Kuo</surname><given-names>MT</given-names></name></person-group><article-title>Effects of Cu(ii) and cisplatin on the stability of Specific protein 1 (Sp1)-DNA binding: Insights into the regulation of copper homeostasis and platinum drug transport</article-title><source>J. Inorg. Biochem.</source><year>2016</year><volume>161</volume><fpage>37</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1016/j.jinorgbio.2016.04.030</pub-id><pub-id pub-id-type="pmid">27172866</pub-id>
</element-citation><mixed-citation id="mc-CR71" publication-type="journal">Yan, D., Aiba, I., Chen, H. H. W. &#x00026; Kuo, M. T. Effects of Cu(ii) and cisplatin on the stability of Specific protein 1 (Sp1)-DNA binding: Insights into the regulation of copper homeostasis and platinum drug transport. <italic>J. Inorg. Biochem.</italic><bold>161</bold>, 37&#x02013;39 (2016).<pub-id pub-id-type="pmid">27172866</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR72"><label>72.</label><citation-alternatives><element-citation id="ec-CR72" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L</given-names></name><etal/></person-group><article-title>Copper overload impairs hematopoietic stem and progenitor cell proliferation via prompting HSF1/SP1 aggregation and the subsequently downregulating FOXM1-Cytoskeleton axis</article-title><source>iScience</source><year>2023</year><volume>26</volume><fpage>106406</fpage><pub-id pub-id-type="doi">10.1016/j.isci.2023.106406</pub-id><pub-id pub-id-type="pmid">37009226</pub-id>
</element-citation><mixed-citation id="mc-CR72" publication-type="journal">Li, L. et al. Copper overload impairs hematopoietic stem and progenitor cell proliferation via prompting HSF1/SP1 aggregation and the subsequently downregulating FOXM1-Cytoskeleton axis. <italic>iScience</italic><bold>26</bold>, 106406 (2023).<pub-id pub-id-type="pmid">37009226</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR73"><label>73.</label><citation-alternatives><element-citation id="ec-CR73" publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Connor</surname><given-names>L</given-names></name><name><surname>Gilmour</surname><given-names>J</given-names></name><name><surname>Bonifer</surname><given-names>C</given-names></name></person-group><article-title>The role of the ubiquitously expressed transcription factor sp1 in tissue-specific transcriptional regulation and in disease</article-title><source>Yale J. Biol. Med.</source><year>2016</year><volume>89</volume><fpage>513</fpage><lpage>525</lpage><pub-id pub-id-type="pmid">28018142</pub-id>
</element-citation><mixed-citation id="mc-CR73" publication-type="journal">O&#x02019;Connor, L., Gilmour, J. &#x00026; Bonifer, C. The role of the ubiquitously expressed transcription factor sp1 in tissue-specific transcriptional regulation and in disease. <italic>Yale J. Biol. Med.</italic><bold>89</bold>, 513&#x02013;525 (2016).<pub-id pub-id-type="pmid">28018142</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR74"><label>74.</label><citation-alternatives><element-citation id="ec-CR74" publication-type="journal"><person-group person-group-type="author"><name><surname>Deacon</surname><given-names>K</given-names></name><name><surname>Onion</surname><given-names>D</given-names></name><name><surname>Kumari</surname><given-names>R</given-names></name><name><surname>Watson</surname><given-names>SA</given-names></name><name><surname>Knox</surname><given-names>AJ</given-names></name></person-group><article-title>Elevated SP-1 transcription factor expression and activity drives basal and hypoxia-induced vascular endothelial growth factor (VEGF) expression in non-small cell lung cancer</article-title><source>J. Biol. Chem.</source><year>2012</year><volume>287</volume><fpage>39967</fpage><lpage>39981</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.397042</pub-id><pub-id pub-id-type="pmid">22992725</pub-id>
</element-citation><mixed-citation id="mc-CR74" publication-type="journal">Deacon, K., Onion, D., Kumari, R., Watson, S. A. &#x00026; Knox, A. J. Elevated SP-1 transcription factor expression and activity drives basal and hypoxia-induced vascular endothelial growth factor (VEGF) expression in non-small cell lung cancer. <italic>J. Biol. Chem.</italic><bold>287</bold>, 39967&#x02013;39981 (2012).<pub-id pub-id-type="pmid">22992725</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR75"><label>75.</label><citation-alternatives><element-citation id="ec-CR75" publication-type="journal"><person-group person-group-type="author"><name><surname>Rigiracciolo</surname><given-names>DC</given-names></name><etal/></person-group><article-title>Copper activates HIF-1&#x003b1;/GPER/VEGF signalling in cancer cells</article-title><source>Oncotarget</source><year>2015</year><volume>6</volume><fpage>34158</fpage><pub-id pub-id-type="doi">10.18632/oncotarget.5779</pub-id><pub-id pub-id-type="pmid">26415222</pub-id>
</element-citation><mixed-citation id="mc-CR75" publication-type="journal">Rigiracciolo, D. C. et al. Copper activates HIF-1&#x003b1;/GPER/VEGF signalling in cancer cells. <italic>Oncotarget</italic><bold>6</bold>, 34158 (2015).<pub-id pub-id-type="pmid">26415222</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR76"><label>76.</label><citation-alternatives><element-citation id="ec-CR76" publication-type="journal"><person-group person-group-type="author"><name><surname>Karginova</surname><given-names>O</given-names></name><etal/></person-group><article-title>Inhibition of copper transport induces apoptosis in triple-negative breast cancer cells and suppresses tumor angiogenesis</article-title><source>Mol. Cancer Ther.</source><year>2019</year><volume>18</volume><fpage>873</fpage><lpage>885</lpage><pub-id pub-id-type="doi">10.1158/1535-7163.MCT-18-0667</pub-id><pub-id pub-id-type="pmid">30824611</pub-id>
</element-citation><mixed-citation id="mc-CR76" publication-type="journal">Karginova, O. et al. Inhibition of copper transport induces apoptosis in triple-negative breast cancer cells and suppresses tumor angiogenesis. <italic>Mol. Cancer Ther.</italic><bold>18</bold>, 873&#x02013;885 (2019).<pub-id pub-id-type="pmid">30824611</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR77"><label>77.</label><citation-alternatives><element-citation id="ec-CR77" publication-type="journal"><person-group person-group-type="author"><name><surname>Lyu</surname><given-names>R</given-names></name><etal/></person-group><article-title>KAS-seq: genome-wide sequencing of single-stranded DNA by N<sub>3</sub>-kethoxal&#x02013;assisted labeling</article-title><source>Nat. Protoc.</source><year>2022</year><volume>17</volume><fpage>402</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1038/s41596-021-00647-6</pub-id><pub-id pub-id-type="pmid">35013616</pub-id>
</element-citation><mixed-citation id="mc-CR77" publication-type="journal">Lyu, R. et al. KAS-seq: genome-wide sequencing of single-stranded DNA by N<sub>3</sub>-kethoxal&#x02013;assisted labeling. <italic>Nat. Protoc.</italic><bold>17</bold>, 402&#x02013;420 (2022).<pub-id pub-id-type="pmid">35013616</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR78"><label>78.</label><citation-alternatives><element-citation id="ec-CR78" publication-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname><given-names>KJ</given-names></name><name><surname>Schmittgen</surname><given-names>TD</given-names></name></person-group><article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2<sup>&#x02212;&#x00394;&#x00394;CT</sup> method</article-title><source>Methods</source><year>2001</year><volume>25</volume><fpage>402</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id><pub-id pub-id-type="pmid">11846609</pub-id>
</element-citation><mixed-citation id="mc-CR78" publication-type="journal">Livak, K. J. &#x00026; Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2<sup>&#x02212;&#x00394;&#x00394;CT</sup> method. <italic>Methods</italic><bold>25</bold>, 402&#x02013;408 (2001).<pub-id pub-id-type="pmid">11846609</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR79"><label>79.</label><citation-alternatives><element-citation id="ec-CR79" publication-type="journal"><person-group person-group-type="author"><name><surname>Orengo</surname><given-names>JP</given-names></name><name><surname>Bundman</surname><given-names>D</given-names></name><name><surname>Cooper</surname><given-names>TA</given-names></name></person-group><article-title>A bichromatic fluorescent reporter for cell-based screens of alternative splicing</article-title><source>Nucleic Acids Res.</source><year>2006</year><volume>34</volume><fpage>e148</fpage><pub-id pub-id-type="doi">10.1093/nar/gkl967</pub-id><pub-id pub-id-type="pmid">17142220</pub-id>
</element-citation><mixed-citation id="mc-CR79" publication-type="journal">Orengo, J. P., Bundman, D. &#x00026; Cooper, T. A. A bichromatic fluorescent reporter for cell-based screens of alternative splicing. <italic>Nucleic Acids Res.</italic><bold>34</bold>, e148 (2006).<pub-id pub-id-type="pmid">17142220</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR80"><label>80.</label><citation-alternatives><element-citation id="ec-CR80" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Metascape provides a biologist-oriented resource for the analysis of systems-level datasets</article-title><source>Nat. Commun.</source><year>2019</year><volume>10</volume><fpage>1523</fpage><pub-id pub-id-type="doi">10.1038/s41467-019-09234-6</pub-id><pub-id pub-id-type="pmid">30944313</pub-id>
</element-citation><mixed-citation id="mc-CR80" publication-type="journal">Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. <italic>Nat. Commun.</italic><bold>10</bold>, 1523 (2019).<pub-id pub-id-type="pmid">30944313</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR81"><label>81.</label><citation-alternatives><element-citation id="ec-CR81" publication-type="journal"><person-group person-group-type="author"><name><surname>Goldman</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Visualizing and interpreting cancer genomics data via the Xena platform</article-title><source>Nat. Biotechnol.</source><year>2020</year><volume>38</volume><fpage>675</fpage><lpage>678</lpage><pub-id pub-id-type="doi">10.1038/s41587-020-0546-8</pub-id><pub-id pub-id-type="pmid">32444850</pub-id>
</element-citation><mixed-citation id="mc-CR81" publication-type="journal">Goldman, M. J. et al. Visualizing and interpreting cancer genomics data via the Xena platform. <italic>Nat. Biotechnol.</italic><bold>38</bold>, 675&#x02013;678 (2020).<pub-id pub-id-type="pmid">32444850</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR82"><label>82.</label><citation-alternatives><element-citation id="ec-CR82" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><etal/></person-group><article-title>Alternative splicing controls teneurin-latrophilin interaction and synapse specificity by a shape-shifting mechanism</article-title><source>Nat. Commun.</source><year>2020</year><volume>11</volume><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">31911652</pub-id>
</element-citation><mixed-citation id="mc-CR82" publication-type="journal">Li, J. et al. Alternative splicing controls teneurin-latrophilin interaction and synapse specificity by a shape-shifting mechanism. <italic>Nat. Commun.</italic><bold>11</bold>, 1&#x02013;17 (2020).<pub-id pub-id-type="pmid">31911652</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR83"><label>83.</label><citation-alternatives><element-citation id="ec-CR83" publication-type="journal"><person-group person-group-type="author"><name><surname>Padilla-Benavides</surname><given-names>T</given-names></name><name><surname>Arg&#x000fc;ello</surname><given-names>JM</given-names></name></person-group><article-title>Assay of copper transfer and binding to P<sub>1B</sub>-ATPases</article-title><source>Methods Mol. Biol.</source><year>2016</year><volume>1377</volume><fpage>267</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-3179-8_24</pub-id><pub-id pub-id-type="pmid">26695039</pub-id>
</element-citation><mixed-citation id="mc-CR83" publication-type="journal">Padilla-Benavides, T. &#x00026; Arg&#x000fc;ello, J. M. Assay of copper transfer and binding to P<sub>1B</sub>-ATPases. <italic>Methods Mol. Biol.</italic><bold>1377</bold>, 267&#x02013;277 (2016).<pub-id pub-id-type="pmid">26695039</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>